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PROLOGUE: of how my involvement in this research began 
Every story has a starting point. During the 2007-2008 academic years, I studied a Master in 
Public Health (MPH), with an International Health concentration, at Harvard School of Public 
Health. While living in Brookline (Massachusetts), I collaborated with a small NGO called 
Brookline-Quezalguaque Sister City (BQSC) Project. Quezalguaque is a rural municipality of 
around 8,000 inhabitants located in the department of Leon (Nicaragua), and was designated 
Brookline's Sister City in 1987. This collaboration has allowed assisting the city in infrastructure 
construction, emergency relief (e.g. hurricane Mitch), and education and health projects, as 
well as building a volunteerism’s network and providing a stimulus for social change. As part of 
this collaborative effort, the Health Committee of the project (where Daniel Brooks, an 
epidemiologist from Boston University participated) decided to address an apparent Chronic 
Kidney Disease (CKD) epidemic in the region, moved by the high mortality due to CKD, as well 
as the increasing concern of the disease among health workers and the general population. 
This project was planning to estimate the prevalence of the disease at this small community 
and to shed light on the possible risk factors causing the disease in Quezalguaque, adding up to 
the ongoing research in the region. This study was carried out during June-August 2008, in 
cooperation with the Universidad Nacional de Nicaragua, in Leon (UNAN-Leon), particularly 
with CISTA (Research Center on Health, Work and Environment), the regional Ministry of 
Health department (SILAIS-Leon), and the Quezalguaque Health Center. 
As part of these efforts, I traveled to Costa Rica during the winter session and met with 
members of SALTRA (a regional program on work and health in Central America funded by the 
Swedish international development agency) at Universidad Nacional de Costa Rica (UNA), to 
understand the work being done on CKD in the region. These meetings were useful in framing 
this public health problem as a regional epidemic of CKD of non-traditional and unknown 
causes. I then traveled to Nicaragua in March 2008 with the BQSC project and spent one week 
working with government officials and UNAN-Leon with the objective of assessing the 
feasibility of the prevalence study, including selecting a local IRB (ethical committee), that 
could review this research. During my stay there, it became clear to me that very few patients 
had access to a full range of treatment including end stage renal disease care such as dialysis 
and kidney transplants in Quezalguaque. Concerns regarding how to perform a risk 
assessment, manage positive screened patients, how to define and classify renal insufficiency 
cases, what is the most efficient way to improve early detection and prevention of progressive 
loss of renal function, and how to prevent or attenuate complications and comorbidities in 
such a context, became the core elements of my master’s thesis, entitled “Evidence-based 
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From May 2011 on, I have been engaged full time with this project, as part of collaboration 
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time spent in the field research activities carried out in Nicaragua. This constitutes the core of 
my PhD thesis with international mention. 
 
 
 
 
 
  
10 
 
 
 
 
 
 
SUMMARY/RESUMEN 
 
11 
 
Introduction 
 
There is a long time neglected epidemic of CKD of unknown causes (CKDu), recently named 
Mesoamerican Nephropathy (MeN), which probably extends from South Mexico to Panama. 
The author of this thesis document has been studying with researchers from Boston University 
this disease since 2009, as part of a mediation process between a sugar cane company and sick 
ex-workers and their families. 
Research Objectives 
1. Describe the epidemiology of CKDu/MeN, and causal hypotheses proposed to date. 
2. Gain a better understanding of the CKDu/MeN causal web, based on Nicaraguan health 
professionals´ perceptions. 
3. Assess kidney damage through urine biomarkers among Nicaraguan adolescents from 
different schools. 
Methods 
In order to address the 3 research objectives proposed, a systematic review of the literature 
published to date, a qualitative study of semi-structured in person interviews with Nicaraguan 
physicians and pharmacists (n=19), and a cross-sectional study of 245 school children from 
different regions of Nicaragua, were conducted. 
Results  
Regarding Objective 1: 
-Mortality rates and prevalence studies have confirmed that communities where agriculture, 
mining and port-related occupations are prevalent, and particularly those in lowlands of the 
Pacific coast are the ones most affected.  Contrary to the typical distribution of a chronic 
[renal] disease, it affects primarily men in their 20-40s (relatively young). Women, although 
less affected, follow also the same distribution as men (e.g. higher prevalence’s in low 
altitude). 
-Risk factors (susceptibility, initiation and/or progression) associated with CKDu in the different 
prevalence and case control studies to date, as well as well known environmental causes of 
CKD thought to play a role in this epidemic, have brought researchers to think that etiology is 
presumably multifactorial.  The variety of hypothesized causes include: heat and heavy 
physical work load (chronic volume depletion), exposure to heavy metals such as arsenic or 
cadmium, agrichemicals, systemic infectious diseases such as leptospirosis, and chronic intake 
of potential nephrotoxic medications such as non-steroidal anti-inflammatory drugs (NSAIDs), 
analgesics or aminoglycoside antibiotics.  
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Regarding Objective 2: 
-Physicians and pharmacists interviewed working in the front line of the disease described it in 
a way consistent with results from the studies conducted so far in the region. 
-Our analysis articulated perceptions of physicians and pharmacists in a causal framework 
where heat stress and subsequent volume depletion experienced by manual laborers may play 
a role in the frequent occurrence of dysuria-like symptoms (locally called “chistata”), which are 
often treated with non-steroidal anti-inflammatory drugs, diuretics and antibiotics that may be 
further nephrotoxic. 
Regarding Objective 3: 
- Adolescents from four schools in three different regions of Nicaragua showed biomarkers of 
kidney tubulo-interstitial damage ranked by mortality rates in the general population by 
region.  For example, the results for NAG were most consistent in this regard, with the relative 
concentrations rank ordered by school according to the mortality rate risk profile in both boys 
and girls. On the other hand, Albumin-Creatinine Ratio, which is primarily associated with 
glomerular damage, did not demonstrate these patterns, and macroalbuminuria measured 
with dipstick, was virtually absent. 
-An unusual finding is that girls had higher levels than boys for all biomarkers, with particularly 
large differences for ACR and IL-18.   
Conclusions 
The epidemiological information on MeN/CKDu is still very narrow and presents several 
limitations, but has helped to describe the distribution of the disease and propose some risks 
factors.  
Dehydration during hard work, and nephrotoxic medications (such as NSAIDs and antibiotics) 
appear as a plausible causal hypothesis that needs to be the focus of further research. Also, 
early risk factors for CKD in the region may be present even during teenage, prior to other 
additionally exposures.  
Multi-level public health responses to the epidemic cannot wait until efforts to identify the 
causes are completed, especially because treatment is not widely available, and poverty and 
premature death are key elements that have turned this disease into a real public health crisis 
of regional dimensions. 
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Introducción 
Nos encontramos ante una epidemia olvidada de enfermedad renal crónica de causas 
desconocidas, denominada recientemente Nefropatía Mesoamericana (NeM), que se extiende 
probablemente desde el Sur de México a Panamá. El autor de esta tesis doctoral ha estudiado, 
junto con investigadores de la Universidad de Boston, esta enfermedad desde 2009 en el 
contexto de un proceso de mediación entre una compañía de la caña de azúcar y ex-
trabajadores y sus familiares.    
Objetivos de investigación 
1. Describir la epidemiología de NeM y las hipótesis causales propuestas hasta la fecha.   
2. Profundizar en el conocimiento sobre la red causal de NeM, basándose en las percepciones 
de profesionales de la salud Nicaragüenses.  
3. Evaluar el daño renal en adolescentes nicaragüenses de cuatro colegios a través de 
biomarcadores urinarios.  
Métodos 
Con la finalidad de abordar los 3 objetivos de investigación propuestos, se realizó una revisión 
sistemática de la literatura publicada hasta la fecha sobre NeM, se llevó a cabo un estudio 
cualitativo de entrevistas personales semi-estructuradas en Nicaragua con médicos y 
farmacéuticos (n=19), y un estudio transversal de 245 escolares en diferentes regiones de 
Nicaragua.    
Resultados 
Respecto al Objetivo 1: 
-La información basada en las tasas de mortalidad y en estudios de prevalencias confirman que 
ciertas comunidades dedicadas a la agricultura, minería, y trabajadores portuarios presentan 
prevalencias de ERC elevadas, particularmente aquellas comunidades localizadas a nivel del 
mar en la Costa del Pacífico. Al contrario de la típica distribución de enfermedad renal crónica, 
NeM afecta principalmente a hombres jóvenes de 20-40 años (relativamente jóvenes). Las 
mujeres, aunque se encuentran menos afectadas, también presentan una distribución similar a 
los hombres (ej. mayor prevalencias en comunidades localizadas a menor altitud).   
-Los factores de riesgo (susceptibilidad, iniciación y/o progresión) asociados a NeM en los 
diferentes estudios de prevalencia y de casos y controles hasta la fecha, así como aquellas 
causas ambientales conocidas de ERC que pudieran tener un papel en esta epidemia, han 
llevado a pensar que la etiología podría ser multifactorial. La variedad de las hipótesis causales 
incluye: exposición al calor y trabajo manual intenso (depleción de volumen crónica), 
exposición a metales pesados como cadmio, o a arsénico, agroquímicos, enfermedades 
infecciones sistémicas como la leptospirosis, el uso crónico de medicamentos potencialmente 
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nefrotóxicas, tales como antiinflamatorias no esteroideos (AINEs), analgésicos o antibióticos 
aminoglucósidos.  
Respecto al Objetivo 2:  
-Los médicos y farmacéuticos entrevistados que trabajan en primera línea de la epidemia 
describen la epidemia de manera consistente con los resultados de los estudios llevados a 
cabo en la región.  
-Nuestro análisis articuló las percepciones de médicos y farmacéuticos en un esquema de red 
causal donde el estrés por calor y la depleción de volumen subsecuente que experimentan 
trabajadores manuales podría jugar un papel en la aparición frecuente de síntomas similares a 
la disuria (llamados localmente “chistata”), que son normalmente tratados con 
antiinflamatorios no esteroideos, diuréticos y antibióticos que pueden ser también 
nefrotóxicos.    
Respecto al Objetivo 3: 
-Los adolescentes de cuatro colegios en tres regiones diferentes de Nicaragua mostraron 
biomarcadores de daño renal túbulo-intersticial en un orden creciente igual al que muestran 
las tasas de mortalidad por ERC en la población general de las mismas regiones.  Por ejemplo, 
los resultados para NAG fueron las más consistentes en este sentido, con concentraciones 
medias relativas por colegio ordenadas según el perfil de riesgo basado en las tasas de 
mortalidad por ERC en su región, tanto para chicos como para chicas. Por otra parte, la razón 
albúmina-creatinina urinaria (RAC), asociada principalmente con daño glomerular, no 
demostró estos patrones, y no hubo evidencia de macroalbuminuria medida con tira reactiva 
de orina. 
-Un hallazgo inusual fue que las chicas presentaron niveles superiores a los chicos para todos 
los marcadores, con diferencias particularmente notorias para IL-18 y RAC.  
Conclusiones 
La información sobre la epidemiología de NeM es aún escasa y presenta múltiples limitaciones, 
pero ha sido esencial para describir la distribución de la enfermedad y proponer algunos 
factores de riesgo.  
La deshidratación durante el trabajo y los medicamentos nefrotóxicos (como AINEs y 
antibióticos) aparecen como una hipótesis causales plausibles que ameritan más investigación. 
Asimismo, algunos factores de riesgo para NeM tempranos podrían estar presentes durante la 
adolescencia, previamente a otras exposiciones adicionales, y requerirían de más 
investigación.     
Las respuestas multinivel de salud pública no pueden esperar a que se completen los esfuerzos 
para identificar las causas de NeM, especialmente porque el tratamiento no es de acceso 
universal y la pobreza y muerte prematura son elementos clave que han convertido esta 
enfermedad en una crisis de salud pública de dimensiones regionales.     
15 
 
 
 
 
 
 
CHAPTER I: GENERAL INTRODUCTION 
Es pobre mi país [Nicaragua] 
pero brilla como un cielo caído al descuido sobre la tierra, 
un cielo como un tapete mullido 
dulce, juguetón, como el abrazo de un niño. 
Gioconda Belli, Nicaragua 2007.  
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1.1 Chronic Kidney Disease:  a global public health problem 
1.2.1 Global burden of Chronic Kidney Disease 
Chronic kidney disease (CKD) is becoming a major public health issue worldwide and an 
important contributor to the overall non-communicable disease burden. CKD is associated 
with major serious consequences including increased risk of premature mortality, end-stage 
renal disease (ESRD), accelerated cardiovascular disease (CVD), mineral and bone disease, 
adverse metabolic and nutritional consequences, infections, reduced cognitive function and 
increased risk of acute kidney injury (AKI) (Levey et al, 2007).  
 
Estimates of the global burden of diseases report that genitourinary diseases were responsible 
annually for 928,000 deaths or 1.6% of the total number of worldwide deaths (12th cause of 
death), and 14,754 000 DALYs, 1% of all global DALYs (17th cause of disability) (WHO, 2004). 
In the United States, as many as 26 million adults may have CKD, an increase from 
approximately 10% of the US adult population between 1988 and 1994 to over 13% just one 
decade later (Coresh et al, 2003; Coresh et al, 2007). This rise in the prevalence of CKD likely 
reflects similar increases in obesity, diabetes, hypertension, and cardiovascular disease (Coresh 
et al, 2007), which are expected to continue to increase in coming years (Levey et al, 2007). 
Similar rates are seen worldwide, with CKD prevalence ranging from 6% to 16% in sample 
populations of Spain (Otero et al, 2010), Japan (Kimura, 2007), and Australia (Chadban et al, 
2003). Systematic review of CKD prevalence studies is arduous because of significant variations 
in methodologies and a lack of a consistent definition for CKD until 2002 (McCullough et al, 
2012).  
 
A considerable proportion of these CKD patients will experience the progression of the disease 
to ESRD, and will need Renal Replacement Therapy (RTT,) such as dialysis or kidney transplant. 
Not surprisingly, 90% of those receiving RRT in the world are in developed countries, and they 
constitute the tip of the iceberg, usually reflected in national registries of ESRD or patients on 
RRT. The cost of treating patients with ESRD is substantial and poses a great challenge to 
provision of care. It is estimated that currently 1,800,000 patients are receiving dialysis 
treatment worldwide at a global cost of US $72 billion and this trend is increasing. In Europe, 
dialysis alone takes up about 2% of health care budgets, with only a small proportion (<0.1%) 
of the population needing treatment (Lameire et al, 2005).  
 
1.1.2 Definitions and classifications of CKD, AKI, AKD 
Defining CKD and classifying the stages of severity permits a common language for 
communication among health care workers, patients and their families, researchers and 
policy-makers as well as a framework for developing a public health approach to affect care 
and improve outcomes of CKD. 
The National Kidney Foundation (NFK) Kidney Disease Outcome Quality Initiative (K/DOQI) 
defined Chronic Kidney Disease for the first time in 2002 as “the presence of kidney damage or 
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decreased level of kidney function maintained for 3 months or more, irrespective of a primary 
diagnosis” (K/DOQI, 2002). This definition is intended to account for all conditions that affect 
the kidney and have the potential to cause either progressive loss of kidney function or 
complications resulting from a decreased level of kidney function.  
Kidney function is usually measured through the glomerular filtration rate (GFR), which 
describes the flow rate of filtered fluid through the kidney, or the creatinine clearance rate 
(CCr or CrCl), which is the volume of blood plasma that is cleared of creatinine per unit time, a 
useful measure for approximating the GFR that usually involves 24-hour urine collection. Both 
GFR and CCr may be accurately calculated by comparative measurements of substances in the 
blood and urine (eg. inulin), or estimated by formulas using just a blood test result (eGFR and 
eCCr). eGFR is estimated using formulas (such as MDRD, CKD-EPI, Cockcroft-Gault, etc) that 
account for age, weight, serum creatinine and other corrective factors such as gender and race 
(which may influence muscular mass). CKD definition is based on the NHANES III study in USA 
(1988-1994) and consists of 5 stages (see table 1.1). In stages 3-5, the level of glomerular 
filtration rate (GFR) is below the “normal” cut-off (60ml/min/1.73m2). Renal disease is often 
progressive once glomerular filtration rate falls below 25% of normal. Early stages of CKD (1-2) 
manifest with only kidney damage in the setting of overtly intact or slightly decreased GFR, 
defined by pathological abnormalities or markers of damage such as proteinuria, including 
abnormalities in blood (serum creatinine), urine tests (urine sediment) biopsies or imaging 
studies.  
Table 1.1 -Stages of CKD 
Stage Description Creatinine clearance (GFR) 
(ml/min/1.73 m2) 
Action 
1 Kidney damage with normal or 
raised GFR 
>90 Screening 
CKD risk reduction 
2 Kidney damage with mildly 
impaired GFR 
60-89 Diagnosis and treatment 
Treatment of comorbidities 
Slowing progression 
3 Moderately impaired GFR (chronic 
renal failure) 
30-59 Evaluating and treating 
complications 
4 Severely impaired GFR 15-29 Preparation for kidney 
replacement therapy 
5 End stage renal disease (uraemia)  15 Replacement 
Source: adapted from National Kidney Foundation—K/DOQI, 2002. 
 
The “Kidney Disease: Improving Global Outcomes” (KDIGO) initiative was born in 2004 
(Eknoyan et al, 2004), trying to integrate and develop different clinical guidelines globally. This 
project has launched new guidelines in 2012 (KDIGO, 2013). The CKD guideline retains the 
2002 definition of CKD but presents an enhanced classification framework for CKD, elaborating 
on the prognosis of the disease (based on results from meta-analyses), and including a 
worldwide used marker of kidney damage: albuminuria (Levey et al, 2011). It also includes 
“heat maps” based on a composite ranking of relative risks of all-causes and cardio-vascular 
mortality, ESRD, AKI, etc. Colors from green to red indicate groups of patients at progressively 
higher risk for the major outcomes, and constitutes a communication tool for clinicians, 
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researchers and the public health agencies to use these risk categories to describe and 
prioritize efforts for patients and populations (see figure 1.1).  
Figure 1.1- Prognosis of CKD by GFR and albuminuria categories. 
 
Source: KDIGO/2012. 
 
CKD definition arbitrarily uses a duration of >3 months (>90 days) as delineating ‘‘chronic’’ 
kidney disease. Nevertheless, in epidemiological studies, kidney damage is usually ascertained 
as albuminuria estimated from the albumin-to-creatinine ratio (ACR) in a random (‘spot’) urine 
sample (or, if not available, sometimes dipstick urine protein and total urine protein-to-
creatinine ratio), and GFR is estimated from serum creatinine. These measurements are made 
at a single point in time, and usually clinical diagnosis is not ascertained. Less than 3 months 
would fall under the category of Acute Kidney Disease (AKD), a very ambiguous term criticized 
by some authors (Palevsky et al, 2013). On the other extreme, acute kidney injury or 
impairment (AKI) is a broad clinical syndrome defined, irrespective of the etiology, as an 
abrupt, within hours to days, decrease in kidney function (see table 1.2). AKI is a predictor of 
immediate and long-term adverse outcomes; it is more prevalent, as well as a significant risk 
factor, for patients with CKD (KDIGO, 2012).  
 
Table 1.2 -AKI definition 
. 
Source: KDIGO, 2012 
AKI severity grades (3 stages) are based on the RIFLE/AKIN criteria (see figure 1.2), which rely 
on Serum Creatinine (SCr) and urine output (Bellomo et al, 2004; Mehta et al, 2007), as 
-Increase in SCr by 0.3 mg/dl (26.5 mol/l) within 48 hours; or 
-Increase in SCr to 1.5 times baseline, which is known or presumed to have occurred within the prior 7 
days; or 
-Urine volume 0.5 ml/kg/h for 6 hours 
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surrogates of kidney damage. More sensitive and specific biomarkers of kidney damage are 
arising (NGAL, KIM-1, IL-18, etc.), but still are not widely used in clinical settings. Some of them 
will be introduced in chapter VI. 
Figure 1.2 -Comparison of RIFLE and AKIN criteria for diagnosis and classification of AKI 
 
Source: KDIGO, 2012 
 
1.1.3 Etiology of CKD 
The causes of CKD are numerous (table 1.3) and typically are divided into vascular, glomerular, 
tubulointerstitial and obstructive etiologies. This classification not only provides a convenient 
pathophysiologic framework, but also may relate to clinical manifestations. Vascular and 
obstructive causes are relatively limited in number and more readily diagnosed, while 
glomerular and tubulointerstitial diseases have a far broader spectrum of causes. Glomerular 
diseases often present with typical urine findings, including proteinuria (consisting primarily of 
albumin), as well as the presence of red blood cells or red blood cell casts in the urine 
sediment. Tubulointerstitial diseases may also have proteinuria; however, this urinary protein 
is often not albumin, but rather includes proteins of tubular cell origin and the total amount 
excreted is usually much lower than that seen in glomerular diseases. White blood cells, renal 
tubular cells, and white blood cell casts may be present in the urine sediment in 
tubulointerstitial diseases, but often the sediment is unrevealing. Clinical features 
distinguishing the different etiologies are more likely to be present early in the course of CKD. 
As CKD progresses to advanced stages, the specific etiology is often not apparent clinically, and 
even biopsies may be of limited yield because late stages of most kidney diseases, regardless 
of etiology, manifest with extensive scarring and fibrosis (Brooks, 2009). 
Remarkably, hypertension and diabetes are the major causes of CKD in developed nations, and 
increasingly in developing countries. In developing nations, chronic viral infections may also 
contribute substantially to the burden of CKD from glomerular diseases (Levey et al, 2007). 
Exposure to nephrotoxic drugs and environmental toxins usually affects the kidney’s tubulo-
interstitial compartment.  
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Table 1.3- Etiopathology differential approach to CKD 
Classification Condition Associated Disease States Manifestations 
V 
A 
S 
C 
U 
L 
A 
R 
Main Renal 
Arteries 
Renal artery stenosis 
Fibromuscular dysplasia 
Often accompanied by hypertension 
Intrarenal 
vasculature 
Thrombotic microangiopathies 
Benign and malignant nephrosclerosis 
Atheroembolic disease 
Minimal albuminuria, often with bland 
urine sediment 
Renal vein Renal vein thrombosis 
May be a cause of or be caused by 
nephrotic syndrome 
G 
L 
O 
M 
E 
R 
U 
L 
A 
R 
Focal GN 
Age <15 yo 
Post-infectious, IgA, TMBD, 
Hereditary nephritis, HSP, 
mesangial proliferative GN 
Active sediment without reduced GFR 
or nephrotic syndrome 
Age 15-40 yo 
IgA, TBMD, SLE, Hereditary 
nephritis, mesangial 
proliferative GN 
Age >40 yo IgA 
Diffuse GN 
Age <15 yo Post-infectious, MPGN 
Active sediment with reduced GFR and 
variable proteinuria 
Age 15-40 yo 
Post-infectious, SLE, RPGNs, 
Fibrillary GN, MPGN 
Age >40 yo 
RPGNs, vasculitides, fibrillary 
GN, Post-infectious 
Nephrotic 
Syndromes 
Age <15 yo 
MCD, FGS, mesangial 
proliferative GN 
Heavy proteinuria, usually bland 
sediment 
Age 15-40 yo 
FGS, MCD, Membranous, 
Diabetes, Pre-eclampsia, Late 
stage post-infectious 
Age >40 yo 
FGS, Membranous, diabetes, 
MCD, IgA, Amyloid/LCDD, 
HTN/nephrosclerosis, Late stage 
post-infectious 
T 
U 
B 
U 
L 
O 
I 
N 
T 
E 
R 
S 
T 
I 
T 
I 
A 
L 
Drugs and toxins 
Analgesic nephropathy (non-steroidal anti-inflammatory 
drugs) 
Aminoglycoside associated nephrotoxicity 
Aristilochic Acid 
Calcineurin inhibitors 
Chemotherapeutic agents (Cisplatin, nitrosureas) 
Contrast induced nephropathy 
Lithium 
Metals (Lead, cadmium, arsenic, uranium, mercury) 
Ochratoxin 
Pigment nephropathy (rhabdomyolysis) 
Minimal albuminuria, usually bland 
sediment, even in presence of reduced 
GFR, tubular proteinuria 
Hereditary  
Fabry Disease 
Hereditary nephritis (Alport syndrome) 
Medullary Cystic Disease 
Polycystic Kidney Disease 
Fabry Disease is rare and may have 
glomerular or tubular manifestations 
Hereditary nephritis is often 
accompanied by hearing impairment;  
Medullary cystic disease may be 
indolent and is difficult to diagnose 
PKD manifests with massively enlarged 
cystic kidneys 
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Autoimmune 
Sarcoid 
Scleroderma 
Sjogren’s syndrome 
SLE 
Other vasculitides 
Highly variable presentations, usually 
with other systemic manifestations and 
typically (except sarcoid) accompanied 
by marked hypertension 
Metabolic 
Cystinosis 
Hyperuricemia 
Hyperoxaluria 
Hypokalemia 
Nephrocalcinosis 
Minimal albuminuria, usually bland 
sediment, even in presence of reduced 
GFR, tubular proteinuria 
Other 
Chronic infections, ureteral reflux 
Chronic ischemia, acute tubular necrosis 
Hypertension 
Lymphoproliferative diseases and myeloma 
Sickle cell disease 
Minimal albuminuria, usually bland 
sediment, even in presence of reduced 
GFR, tubular proteinuria 
O 
B 
S 
T 
R 
U 
C 
T 
I 
O 
N 
Ureteral 
Bilateral obstructing stones (or unilateral if single 
functional kidney) 
Malignancy 
Strictures 
Retroperitoneal fibrosis May have hematuria, but otherwise 
bland sediment 
Bladder 
Benign or malignant prostate enlargement 
Urethral stricture 
Neurogenic bladder 
Infections 
Medications 
FGS, focal glomerulosclerosis; TMBD, thin basement membrane disease; HSP, Henoch Schonlein purpura; GN, glomerulonephritis; 
SLE, Systemic lupus erythematosus; MPGN, membranoproliferative glomerulonephritis; RPGN, rapidly progressive 
glomerulonephritis; MCD, minimal change disease; LCDD, light chain deposition disease; HTN, hypertension 
Source: Brooks, 2009 
There are likely multiple risk factors involved in CKD each stage (Levey et al, 2007).  These can 
broadly be conceptualized as development factors and progression factors (table 1.4).  
Development factors include susceptibility factors (which increase vulnerability to kidney 
damage, with examples including older age, family history/genetic predisposition, and even 
elements like volume depletion), and initiation factors (which actually cause kidney damage, 
with examples including diabetes, autoimmune diseases and toxins). Progression factors cause 
worsening damage and progressive decline in GFR, with examples including higher blood 
pressure, smoking and poor diabetes control. Certain factors, with sustained exposure, may 
even fall into more than one of these categories. For example, low birth weight and CKD may 
be related with a defective nephrogenesis provoked by intrauterine malnutrition. Early post-
natal malnutrition is also linked to overweight in adulthood and ultimately develops into 
diabetes and diabetic nephropathy (Codreanu et al, 2006).  
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Table 1.4 - Risk factors for CKD 
Factor Category Definition Examples 
Development 
  
Susceptibility 
Increase susceptibility to kidney 
damage 
Older age, family history of CKD, low kidney 
mass/low birth weight, minority status, low SES, 
volume depletion 
Initiation Directly cause kidney damage 
Diabetes, hypertension, autoimmune diseases, 
systemic infections, recurrent urinary tract 
infections, nephrolithiasis, obstruction, drug toxicity 
Progression 
Cause worsening kidney damage 
and more rapid decline in GFR 
Higher levels of proteinuria, higher blood pressure, 
poor diabetes control, smoking, cardiovascular 
disease 
Source: Brooks, 2009. 
 
1.2 Clusters of CKD around the globe 
As mentioned previously, CKD is considered a key contributor to the global burden of non-
communicable diseases, being a key determinant of the poor health outcomes of chronic 
diseases, but also a consequence of diabetes and hypertension, highly prevalent currently 
across the general population. 
However, the causes of CKD are multiple (see table 1.3), and its distribution sometimes follows 
a geographical cluster, affecting particular segments of the population. For example, an 
increased prevalence in Pima Indians and Australian Aborigines has been associated with a 
high prevalence of diabetes and possibly low birth weight linked to a decrease in renal mass 
and nephrones (Hoy, 2000).  
In other populations, environmental toxins, particularly heavy metals, have been identified as 
a cause of CKD (Soderland et al, 2010). Although clusters of CKD induced by heavy metals 
usually occur among industrial workers in occupational settings, whole populations could be 
exposed through food or water. Examples include the appearance of a cadmium nephropathy 
along the Jinzu river (Japan), associated with contaminated rice, or a nephropathy due to 
organic mercury poisoning along the Minamata Bay in Japan, associated with the ingestion of 
mercury contaminated fish (Iesato et al, 1977; Jarup, 2002). 
Other environmental toxins have been identified as causes of CKD.  In Tunisia, contamination 
of the food supply with ochratoxin A, a nephrotoxic mycotoxin, has been linked to an 
increased prevalence of CKD (Abid et al, 2003).  But certainly, a striking case (because of its 
regional multi-country scope and the amount of time it has taken to elucidate its causes) is the 
Balkan endemic nephropathy (BEN) (Bamias e tal, 2008; Debelle et al, 2008).  BEN is a form of 
interstitial nephritis, first identified in the 1920s (although first published in the 1950s) among 
several small communities along the Danube River and its major tributaries, in the modern 
countries of Croatia, Bosnia and Herzegovina, Serbia, Romania and Bulgaria. Although the 
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etiology for BEN is not fully certain, chronic exposure to dietary aristolochic acid is known to be 
the major risk so far. At the beginning, heavy metals and ochratoxin A were hypothesized as 
causes, but an outbreak in 1993 of CKD among users of a Chinese herbal medicine for weight 
loss at a clinic in Brussels restarted the investigation on aristolochic acid, a toxic product 
produced from the seeds of Aristolochia clematitis (birthwort).  In 1967, this theory had been 
proposed, that Balkan nephropathy was caused by the contamination of the baking flour in 
endemic areas by seeds of Aristolochia clematitis, but this hypothesis had not garnered much 
attention.  However, the clinical manifestations of the disease in these patients (mostly 
women) were remarkably similar to those seen in the Balkans, with similar morphologic 
characteristics and the occurrence of uroepithelial tumors. The subsequent identification of 
aristolochic-specific DNA adducts in urinary tract tissue from patients with Balkan nephropathy 
and the development of an animal model (Debelle et al, 2002), has pointed out aristolochic 
acid as BEN’s most probable cause. 
Other clusters of CKD with unknown causes remain still unsolved. An apparently new form of 
chronic kidney disease of unknown etiology (CKDu) has emerged in several areas of Sri Lanka, 
comprised in the North Central Region of the island (Athuraliya et al, 2011). This Sri Lankan 
CKDu is not related to diabetes, hypertension, or any other traditional causes of chronic kidney 
disease. The disease is characterized by a slow, progressive, asymptomatic development, 
frequently starting at a young age group.  Hospital statistics suggest that as many as 8,000 
people are currently undergoing treatment for this condition. The disease is more prevalent 
among men engaged in agriculture, usually from a low socio-economic status. CKDu in this 
country has become a major public health problem, with a big social and economic impact, 
that has brought the Ministry of Health and the World Health Organization to conduct 
research and design public health interventions (WHO, 2010). One of the major tasks 
undertaken is the establishment of a National Registry of CKDu in Sri Lanka. Recent research 
conducted by the Sri Lankan MoH and WHO included prevalence studies, biological and 
environmental sampling. Results point exposure to arsenic, cadmium and agrichemicals as 
possible risk factors associated (WHO, 2013).  
There are anecdotic reports of similar CKD epidemics in the South-East coast of India 
(Machiraju et al, 2009), or in Egypt (Kamel et al, 2010), but much less information is available 
on them. Whether or not these clusters of CKD of not yet known causes are similar to that 
occurring in the Central American region remains unknown. 
 
1.3 A new epidemic cluster: Mesoamerican Nephropathy (MeN) or CKD 
of unknown causes (CKDu) in the Central American region 
A new epidemic of chronic kidney disease in several areas of the Mesoamerican region, 
defined as a nephropathy of non-traditional etiology that usually affects young adult males 
from rural communities is currently being detected in the lowlands of the Pacific coast 
(Wesseling et al, 2013). The causes of the disease remain basically unknown. However, it is 
now known with certainty that this epidemic constitutes a public health problem of substantial 
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magnitude and severity. For example, in El Salvador, CKD appears as the second cause of 
mortality in adult males (El Salvador MoH, 2007).  
Main milestones around this novel disease concentrate in the last 2 decades. Although some 
internal medicine physicians and nephrologists of reference national hospitals (e.g. personal 
communication with Dr. Norman Jirón, Managua, 2009) date back to as far as the 70’s, this 
unusual increase of cases among young males coming from rural and coastal areas of 
Honduras, El Salvador, Nicaragua and Costa Rica, it is not until the mid-2000 decade that series 
of cases and small studies started to appear in peer-review journals or formal reports (Garcia-
Trabanino et al, 2002; Dominguez et al, 2003; Cerdas, 2005; Garcia-Trabanino et al, 2005; 
Cuadra et al, 2006). And it is not until the current decade that community based prevalence 
studies (some with case control nested sub-analysis) are finally undertaken and published, 
with government figures being also shared to the broader community.  
 
Recently, the epidemic has also gained attention from the regional and international public 
health agenda.  Governments of Central America and the Pan American Health Organization 
(PAHO) have recognized that this epidemic (named the Mesoamerican Nephropathy, MEN, or 
Chronic Kidney Disease of unknown or non-traditional causes, CKDu) is a real threat to public 
health in the region. The Commission of National Ministries of Health of Central America 
(COMISCA) signed a declaration in 2012 prioritizing this epidemic and calling governments into 
action, and in 2013 a high level meeting on “CKD of unconventional causes in Central America” 
was convened in El Salvador1. Also, researchers from more than ten countries got together in 
San José, Costa Rica, in November 2012, under the umbrella of SALTRA (Program in Health, 
Work, and Environment in Central America), coordinated from the Central American Institute 
for Studies on Toxic Substances (IRET) of the Universidad Nacional (UNA) in Costa Rica. As part 
of that workshop, a Technical Report (Wesseling et al, 2013), that contains reviews of different 
topics by many researchers, was released in 20132. This report calls for urgent and 
collaborative actions to elucidate the causes and find solutions for prevention and mitigation. 
Also, as a result from this meeting, a Research Consortium with a Board of Directors has been 
created with its main role to advocate in favor of CKDu/MeN, and coordinate research efforts. 
Finally, very recently (June 17th, 2013), PAHO dedicated its 152nd Executive Committee Session 
to the topic “Chronic Renal Disease in Agricultural Communities of Central America”, 
delineating the main strategic objectives for interventions at national and regional levels and 
proposing a permanent technical group of experts to assess national governments on this 
public health issue (PAHO, 2013).  
Along with this prioritization in the public health agenda of the region, mass media has also 
echoed the epidemic, particularly the implications of this tragedy (focusing on its human faces) 
that devastates communities. Examples are BBC3, The Guardian4, El Pais5, and many national 
newspapers6. 
                                                          
1
 San Salvador declaration can be found at: 
http://new.paho.org/els/index.php?option=com_content&task=view&id=778  
2
 The technical report is publicly available at http://www.regionalnephropathy.org 
3
 http://www.bbc.co.uk/news/magazine-16007129  
4
 http://www.theguardian.com/world/2012/oct/14/kidney-disease-killing-sugar-cane-workers-central-america 
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Chapter 4 of this thesis will attempt to document and describe the epidemiology (where, who, 
when) of this epidemic based on mortality data, and the outcomes of the peer-reviewed 
manuscripts published to date. 
1.4 Investigating MeN/CKDu in Nicaragua 
The research work presented in this document took place in a unique context full of 
complexities and stakeholders that played an important role in the research process, and that 
it is worth mentioning here.  
Boston University School of Public Health (BUSPH) was contracted in 2009 by the Compliance 
Advisor/Ombudsman’s office (CAO) of the World Bank to investigate the cause(s) of this two 
decade-long unexplained excess occurrence of CKD in Central America. Such a process was 
initiated by a complaint filed by the NGO: Center for International Environmental Law (CIEL), 
on behalf of the Asociación de Chichigalpa por la Vida (ASOCHIVIDA), a community-based 
organization of individuals suffering from CKD- or their widows- who formerly worked at the 
sugar cane fields of Ingenio San Antonio (ISA), which is owned by National Sugar Estates 
Limited (NSEL). The complaint alleged that the International Finance Corporation (IFC), and 
Multilateral Investment Guarantee Agency (MIGA), of the World Bank Group failed to address 
the health and well-being of workers or the environment when delivering a substantial loan to 
NSEL, the primary example of harm being the CKD epidemic.  
In response to the initial complaint, CAO proposed a mediation (or “Dialogue”) process 
between representatives of ASOCHIVIDA and NSEL. Dialogue meetings led (among other 
activities such as exploring options for improved care or alternative income generation 
projects for affected community members) to a request for applications to prepare a scoping 
study to consider the questions of what are the causes of CKD in the Western region of 
Nicaragua, and, whether there is any relationship between the practices of the ISA and the 
causes of CKD.  
BUSPH was selected by the Dialogue participants to conduct this scoping study, and assembled 
a multidisciplinary and multi-country team of researchers with expertise in epidemiology, 
occupational and environmental health, nephrology, and public health experts. During the 
second half of 2009, we reviewed the existing information available on CKD in Nicaragua and 
Central America, identified data gaps, evaluated the feasibility and usefulness of additional 
studies and design options that could yield the necessary information to answer the Dialogue 
                                                                                                                                                                          
5
http://sociedad.elpais.com/sociedad/2011/12/25/actualidad/1324846356_918435.html, 
http://internacional.elpais.com/internacional/2013/05/14/actualidad/1368496548_623955.html,  
http://internacional.elpais.com/internacional/2012/02/11/actualidad/1328991118_487033.html?rel=rosEP 
6
 http://www.confidencial.com.ni/articulo/5638/miles-de-caneros-mueren-por-enfermedad-renal  
http://www.nacion.com/2012-08-15/AldeaGlobal/fallas-renales-en-guanacastecos-triplican-las-del-promedio-del-
pais.aspx 
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members’ questions.  Some of those studies7 we carried them out in a second phase contract 
during 2010-2012, and included:  
 An industrial hygiene/occupational health assessment (August 2010), which 
evaluated the potential hazards associated with chemicals and work practices at ISA; 
 An investigation of water quality (August 2010), which included the analysis of a large 
number of contaminants in water samples collected from locations selected by 
ASOCHIVIDA; 
 A qualitative analysis of interviews with physicians and pharmacists (September 
2011), which summarized data from semi-structured interviews with health 
professionals in Nicaragua to assess their perceptions regarding renal disease in the 
region; 
 A pilot cohort study (February 2012), which assessed the feasibility of conducting a 
complete retrospective cohort study to evaluate the relationship between work 
practices at ISA and CKD; 
 An investigation of biomarkers in workers (April 2012), which evaluated biological 
markers of kidney injury and CKD in ISA workers, miners, construction workers, and 
port workers; 
 An investigation of urinary biomarkers in adolescents (June 2012), which evaluated 
evidence of subclinical kidney damage among adolescents in different areas of 
Nicaragua. 
Outcomes from these research activities have not yielded the silver bullet answer to those 
initial research questions, but have served to gather a lot of important information, better 
described the epidemiology of the disease, and provided clues regarding concrete risk factors. 
Finally, they have contributed to raise awareness and create momentum (along with efforts by 
many other researchers) to study this serious public health problem. Some of these results, 
where I have had a leading role, are presented in the upcoming chapters of this PhD thesis. 
 
  
                                                          
7 Reports for all studies conducted can be found at: http://www.cao-ombudsman.org/cases/document-links/links-
82.aspx  
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CHAPTER II: THEORETICAL FRAMEWORK 
“When elephants fight, it is the grass that suffers.” 
-African proverb.  
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Causation of CKDu/MeN is not well established yet, but the evidence available points towards 
a multicausal model, where the influence of diverse groups of factors operating at various 
levels, from the molecules up to the social and economic determinants, and environmental 
aspects (including the relationships between humans and the natural ecosystem) should be 
considered. Furthermore, theoretical models that embrace different levels could help 
envisioning the environmental, biological and social factors that contribute to and/or influence 
the development of CKD, how they relate to each other, and the embedded complexity of the 
causal framework (“Working with an ecosystem perspective” Mergler D, Jakobsson K, Ramírez-
Rubio O. In: Wesseling et al, 2013, pp 163-15). Socio-ecological models of health described in 
this chapter include multiple levels of causation to explain health and disease, and are helpful 
as a starting point to explain and draw the lines, in which CKDu/MeN and its context are 
circumscribed, as well as to frame and structure the recommendations that emerge from this 
work. 
2.1 Socio-ecological models of health   
Several models have emerged in the last decades that consider a systemic perspective of 
health problems (see table 2.1). These models analyze the multiple levels of factors 
(psychological, social, and organizational) that influence health behaviors, and how those 
factors interact across those levels (e.g. individual, organizations, communities, policy 
environments, etc). This analysis is particularly relevant when the intention behind is designing 
effective multi-level interventions aimed at changing behavior (e.g. smoking cessation). These 
models, strongly based on the behavioral sciences and public health paradigms, try to explain 
the nature of people’s transactions with their environments.  
Table 2.1- Examples of models designed to explain behavior 
Model Author (year) 
Ecological psychology Kurt Lewin (1951) 
Environmental Psychology Roger Barker (1968) 
Social Ecology Rudolph Moos (1980) 
Systems Theory Urie Bronfenbrenner (1979) 
Ecosocial Model Thomas Glass and Matthew McAtee (2006) 
 
Many authoritative documents that guide public health programs nationally and 
internationally are based on these models and principles. For example, the Ottawa Charter 
(WHO, 1986) took a step forward understanding health as a responsibility beyond the health 
care system, building on the discussions generated by the Declaration on Primary Health Care 
at Alma-Ata (WHO, 1978), and the World Health Organization's “Targets for Health for All” 
document signed in 1984 by the member states of the European region (WHO, 1984).  
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Figure 2.1- Ottawa Charter logo. 
 
Source: WHO, 1986. 
 
However, the word “ecological” in all these frameworks refers to the inclusion of multiple 
levels of factors affecting human health (including the environment), rather than the 
preservation and sustainability of our ecosystem or the natural environment itself (i.e. the 
interaction of living organisms such as plants, animals and microbes, and the nonliving 
components of their environment like air, water and mineral soil), which also has radical 
effects on humans health (e.g. access to safe water, food, energy, etc).  
 
Despite the converging interest in linking the upstream social and environmental determinants 
of health, the fields of “environmental health” and “social determinants of health” have 
tended to remain conceptually and operationally distinct (Parkes et al., 2003). Slowly, the 
significant link among ecosystem change, social inequalities and health has also started to 
influence those whose primary focus is the social determinants of health. Research around 
these social determinants have tended to focus on health inequities in relation to social 
gradient, stress, early life, social exclusion, work, unemployment, social support, addiction, 
food and transport (Wilkinson et al, 2003). While at first glance these themes may seem 
unrelated to the themes of ecosystems and health, connections are beginning to be made.  
 
For example, the WHO Commissioner on the Social Determinants of Health clearly identified 
the links between the social determinants of health and the effect of environmental change on 
health inequities: 
“Putting all these levels in context is the natural environment, and the macro-level to micro-
level effects of environmental change. Risks to health include heat waves and other extreme 
weather events, changes in infectious disease patterns, effects on local food yields and 
freshwater supplies, impaired vitality of ecosystems, and loss of livelihoods. If present trends 
continue the adverse health effects from human induced environmental changes will be 
distributed unequally. The poor, the geographically vulnerable, the politically weak, and other 
disadvantaged groups will be most affected…Addressing the intersection between social 
determinants of environmental change and the effect of environmental change on health 
inequities will benefit sustainable ecological and population health alike.” (Marmot, 2007, 
p.1156) 
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Those connections have also occurred at the “policy level”. For example, “Health in All 
Policies”(HiAP) is an incipient approach to policy making first used by the Finnish Presidency of 
the European Union (EU) in 2006, in which decision-makers in other sectors (e.g. urban 
planning and environment protection) routinely consider health outcomes, including benefits, 
harms, and health related-costs, strengthening the link between health and other policies.  
2.2 Eco-health, a new comprehensive model   
It is in that conceptual battle, that EcoHealth emerges at the interface between ecological and 
health sciences, with the purpose of studying the interactions between environment, 
development, sustainability, and health across local, regional, and global scales. This 
ecosystem approach to public health issues acknowledge the complex, systemic nature of 
public health and environmental issues, and the inadequacy, to some extent, of conventional 
methodologies for dealing with them. Thus, this approach is inherently transdisciplinary, 
recognizing complex biophysical, social, cultural, political and economic relationships between 
the ecosystem and human health, and embracing concepts such as social justice, gender 
equity, multi-stakeholder participation and sustainability. Practitioners of social and political 
disciplines; biology, epidemiology, veterinary and human medicine, and public health; are key 
to understand these drivers of social and ecosystem change, and their ultimately influence in 
human health and well-being. This integrative thinking aims to better understand processes 
such as climate change, loss of biodiversity, antibiotic resistance, health inequalities, 
degradation and pollution of air, land, water resources, etc.; and how they are affecting our 
health (Wilcox et al, 2004).  
Ecosystem management offers a strategy for what McMichael et al (2008) describe as “true 
primary prevention” by reducing or eliminating the human pressures on the environment that 
create disease and health inequities, as well as lessening existing health risks for vulnerable 
communities.  
Ecosystem approaches to health arose in the 1990s in Canada from a group of experts dealing 
with diverse problems ranging from Great Lakes contamination to zoonotic diseases. Canada's 
International Development Research Centre (IDRC) played a lead role in supporting an 
international community of scientists and scholars who advanced ecosystem approaches to 
health (Webb et al, 2010). The launch of the journal EcoHealth (Wilcox et al, 2004), the official 
publication of the “International Association for Ecology and Health” since its formation in 
2006, gave further impetus to the emerging field, providing an integrated, international 
platform for dissemination, peer-review and scholarly development. Ecohealth has also been 
cultivated through recognition of the common ground with the field of “conservation 
medicine” (Aguirre et al., 2002), and what is sometimes described as “One Health”—linking 
human and animal health with increased attention to ecosystem context (Zinsstag et al., 2008). 
There are several conceptual models that seek to frame the relationships between 
environmental and social determinants of human health (VanLeeuwen et al, 1998; Parkes et al, 
2003; Millennium Ecosystem Assessment Board, 2005). One of them, is the DPSEEA framework  
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(see figure 2.2), pronounced “deep sea”, that stands for Driving forces, Pressures, State, 
Exposure, Effects and Actions; and was developed as part of the HEADLAMP (Health and 
Environment Analysis for Decision Making) Project, a collaboration of the World Health 
Organization, the United Nations Environment Program and the United Nations Environmental 
Protection Agency in the early and mid-1990s (Corvalan et al, 2000). Although simplistic and 
formulated only thinking on negative exposures and health effects (thus, not taking into 
account positive health promotion through the environment), it emphasizes action. It makes 
the point that intervention in environmental contexts to improve human health can be 
targeted at a variety of scales, and by different actors. This multi-step action model addressing 
upstream and downstream factors has guided also the exercise of outlining public health 
interventions for MeN/CKDu (see Chapter “Recommendations”).  
Figure 2.2- The DPSEEA model 
 
Source: Carneiro et al., 2006, adapted from Corvalan et al., 2000. 
 
2.3 Epidemic of CKDu/MeN in Central America with an Eco-Health 
perspective 
While one can pinpoint specific causal pathways for each 21st century epidemic (both 
re/emerging infectious and chronic diseases), they probably reflect more general systemic and 
cultural changes, including population growth and mobility, a huge shift in agriculture to 
economies of scale and mass distribution, land use changes, physical activity patterns; and 
ultimately, better detection methods and a more public alert.  
Along these lines, CKDu/MeN is a two decade-long unexplained excess occurrence of chronic 
kidney disease, that has been repeatedly neglected by many institutions because of the 
uncertainty regarding its causes, and the complex social, ecological, and economic drivers that 
seem to surround the disease. Although the causes of the disease are still unknown, most 
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seem to relate to environmental and/or occupational exposures. It can be argued that climate 
change and non sustainable environmentally development may be behind some of the causes 
and/or drivers of the epidemic (see table 2.2).  
Table 2.2- Eco-health dimensions of CKDu/MeN 
 Downstream- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -Upstream 
 Micro level 
(e.g. individuals and 
families) 
Meso level 
(e.g. communities) 
Macro level 
(e.g. Pacific Coast 
Mesoamerica) 
Ecological 
dimension 
-Subsistence farming 
-Individual unsafe water wells 
-Monoculture (e.g. sugar 
cane, cotton) 
-Use of agrichemicals and 
safety issues 
-Extreme weather events 
(e.g. flooding) 
-Volcanic area 
-Contamination of 
community water sources 
-Degraded ecosystems 
-Deforested lands 
-Loss of biodiversity 
-Tropical climate (high 
temperatures and 
humidity) 
-Increasing 
temperatures (global 
warming) 
 
Socio-economic 
dimension 
-Lack of economic gain 
possibilities 
-Poor households 
-No land owning 
-Limited access to social 
security and pension benefits 
-Lack of access to secondary 
and higher education 
-Movement of populations 
and human settlements (e.g. 
civil wars in Nicaragua and El 
Salvador, migrant workers, 
etc) 
-Gender differences at work-
force  
-Mistrust on large companies, 
that have distanced from 
workers and their 
communities through 
subcontracts 
-International political 
economy 
-Agribusiness 
-Free trade zones and 
working places 
-Weak labor norms’ 
supervision and 
enforcement 
Health care 
dimension 
-Limited access to health care, 
particularly specialized care.  
 
-Mandatory screenings of 
creatinine prior to work 
(renal health as a pre-
condition to work) 
-At health care settings: 
limited resources, burnt out 
personnel 
-Susceptible populations 
to multiple infections 
and disease (inc. CKD) 
-Health care and Public 
Health regional 
institutions lack of 
action 
Emotional 
dimension  
-Widowhood and orphanage 
-Stigma 
-Affected communities with 
hundreds of lost members 
(mostly young males), and 
“no space at cemeteries” 
-Lack of trust in public 
institutions 
Source: Ramirez-Rubio, O (2013), adapted from Ali (2004).  
From an ethnographic point of view, the profile of a “typical” CKDu / MeN affected person8 is a 
young man (although women are also known to suffer from CKDu) of 20-40 years, usually a 
farmer or field worker (but not always) clearly trapped in a poverty cycle. The dynamics are 
different in each community, but usually most studied areas, located on the Pacific coast of El 
Salvador, Nicaragua and Costa Rica, are similar: large deforested coastal areas of land devoted 
to cultivate single crops (sugar cane, peanuts, cotton, etc), and separated from the inner land 
by a volcanic range. The cycle of poverty is increased with the burden of this disease, very 
debilitating and marked by a silent and chronic progression in which the only treatment is 
renal replacement therapy (dialysis or renal transplantation), barely accessible in these 
                                                          
8
 For a portrait of these situations, watch videos:  http://www.youtube.com/watch?v=4c3kNNqfBDQ, 
http://www.youtube.com/watch?v=I1ki-mL_rv4 
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countries. Health systems are overwhelmed by the lack of resources, and trained and 
motivated health workers. Large companies become the main screening centers, testing their 
employment seekers and discovering the iceberg of the epidemic.  
Affected families and communities are being overwhelmed by the disease, finding no 
responses from local or national authorities. The burden of stigma, widowhood and orphanage 
is normally borne by women. Although probably anecdotic, affected men have abandoned 
their families and home after a diagnosis of a terminal CKD (personal communication with one 
of the psychologists of Hospital España, Chinandega, specialized in HIV/Aids and CKD, 2009). 
Also, the fact that the cause is unknown puts pressure on "individual" behaviors that are 
questioned (alcohol, drugs and tobacco consumption, nutrition habits, hygiene and home 
conditions) as possible initiation or progression factors of the disease. 
This is the crude context in which advocacy, companies’ social responsibility actions, 
mediation, public policy planning, and even research occurs. 
Figure 2.3- Members of the same family affected by CKD 
 
Source: La Isla Foundation 
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CHAPTER III: RESEARCH HYPOTHESES 
AND OBJECTIVES  
“The real voyage of discovery consists not in seeking new landscapes, but in having 
new eyes”.  
- Marcel Proust 
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3.1 Research Plan 
As outlined in Chapter I, we started to investigate this epidemic of CKD of unknown causes in 
2009, in the context of an occupational dispute among sick sugar cane ex-workers and the 
company where they used to work. One of the first research questions posed by the dialogue 
members was when, where and who was affected by this disease. Back that year the 
information to this respect was limited and mainly based on non-published national statistics, 
reports, and bachelor and master’s theses.   
In 2013, there are already 7 community prevalence studies (some with case-control studies 
embedded) with some sort of random sampling, which will be reviewed in Chapter IV, along 
with mortality rates by region, year and sex from some of the Central American countries. 
Also, key results from a follow-up study of sugar cane workers during a harvest season that has 
not yet been published (McClean et al, 2012) will be included.  Main causal hypotheses argued 
to date by researchers, as well as the main risk factors of susceptibility, initiation and/or 
progression being explored on the published studies will be outlined. This review exercise 
describing the epidemiology of the disease and its key aspects has been undertaken in two 
commissioned editorials in peer-reviewed journals (Brooks et al, 2012; Ramírez-Rubio et al, 
2013a) annexed in this document, and as a chapter of a technical report (Brooks & Ramirez-
Rubio, in Wesseling, 2013).  
Additionally, during the process of conducting field research, we learned from members of the 
mediation process, and from informal discussions with area physicians and workers, of the 
frequent occurrence of a set of symptoms seemly related to dehydration, referred to locally as 
“chistata,” characterized by painful urination and often accompanied by “kidney” and/or back 
pain, and the common diagnosis of urinary tract infections (UTIs) among young men. Since the 
list of CKD potential causes is extensive but includes the use of nephrotoxic medications as an 
additional risk factor, we decided to conduct a qualitative research based on interviews in 
Chinandega and Leon (regions with the highest CKD mortality rates in Nicaragua) both with 
physicians who are likely to diagnose or treat chistata, UTI, and/or CKD and with retail 
pharmacists who are likely to fill prescriptions or sell medications to treat these conditions. 
This piece of research is presented in Chapter V, along with its publication in a peer-reviewed 
journal (Ramirez-Rubio et al, 2013b). 
 
Studies to date have focused on the general adult population or working population at 
occupational settings. However, since most of these affected workers are diagnosed with CKD, 
which is a chronic and progressive loss in renal function over a period of months or years, at 
very young ages; and because most of the hypothesized environmental/occupational 
exposures could already be happening (perhaps with less intensity) earlier in life; we were 
interested in studying whether initial damage may begin in childhood. After our experience 
using new biomarkers of kidney damage among workers (detecting significant differences 
depending of job task undertaken and showing increases along the harvest season in certain 
jobs) (McClean et al, 2012), we decided to use those in adolescents before they start working 
in very different regions of Nicaragua (with presumed different environmental exposures and 
family history of CKD). The results of this pilot study are presented in Chapter VI, along with its 
manuscript that it is in the process of submission to a peer-reviewed journal. 
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Finally, public health responses to the epidemic cannot wait until efforts to identify the causes 
are completed, especially because treatment is not widely available, and poverty, stigma, and 
premature death are key elements that have turned this disease into a real public health crisis. 
Thus, key public health interventions will be outlined in a Recommendations Chapter, along 
with a Brief Policy Paper that was commissioned by Instituto de Salud Carlos III, as a request by 
the Ministry of Health of Costa Rica in the context of bilateral cooperation projects that both 
institutions share (see Annexes).  
3.2 Objectives 
Concrete objectives of the activities outlined in the research plan are: 
 
Objective 1 
Despite its scientific and public health importance and its potential global reach, most health 
researchers and public health practitioners are unaware of this epidemic. The goal of Chapter 
IV is to describe the epidemiology of MeN/CKDu (frequency of mortality, morbidity, 
geographical, sex and age distribution), and establishing the causal hypotheses and 
relationship between development and progression risk factors, by conducting a review of the 
literature published to date on MeN/CKDu in Central America.  
 
Objective 2 
While there has been a great deal of media and activism focused on CKD and potential causes 
in Nicaragua, general knowledge, opinion or practice of physicians and pharmacists in the 
region are not known. The aim of the qualitative semi-structured interviews presented in 
Chapter V is to increase our understanding of health professionals´ perceptions regarding CKD 
in the region (characteristics of the affected population, causal hypotheses, symptoms, 
diagnostic tools, treatment and prognosis); in order to get a deeper understanding of 
MeN/CKDu causal web, and determine whether further study of the relationship among 
hydration practices, diagnosis of UTI/chistata and use of medications is warranted. 
 
Objective 3 
The aim of the pilot study presented in Chapter VI with adolescents in different schools of 
Nicaragua (selected based on a priori risks) is to assess kidney damage through urine markers 
of tubule damage; as well as urine albumin, a traditional marker of increased glomerular 
permeability and damage, and urine dipsticks; and note differences between schools, if any.  
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CHAPTER IV: EPIDEMIOLOGY, RISK 
FACTORS, AND CAUSAL HYPOTHESES 
FOR MeN/CKDu 
"The art of epidemiological thinking is to draw conclusions from imperfect data"     -
George W. Comstock- 
 
“But not too strong conclusions and not too imperfect data…” - 
… adds Daniel Brooks-  
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4.1 Introduction 
For almost two decades, large areas of Central America have been impacted by an under-
recognized epidemic of chronic kidney disease of unknown causes (CKDu) whose victims are 
disproportionately young and male (Ramirez-Rubio et al, 2013a). Exact figures are unavailable, 
but El Salvador, for example, has the highest overall mortality from kidney disease in the world 
(with Nicaragua also included in the ten highest countries) (WHO, 2008), and CKD is the second 
leading cause of mortality among young males in the country (El Salvador MoH, 2009). Very 
recently COMISCA (Central American Ministries of Health) and PAHO (PAHO, 2013), signed the 
“El Salvador Declaration”, declaring this epidemic of CKDu or CKD of non-traditional causes, a 
regional public health threat. Also, researchers working in this topic in the region named the 
CKDu, the “Mesoamerican Nephropathy” or MeN (Wesseling et al, 2013). 
Despite its scientific and public health importance and its potential global reach, very little has 
been published around this epidemic. The goal of this review is to provide an overview of the 
epidemiologic, etiologic, and public health dimensions of the epidemic, by summarizing the 
evidence published to date and identifying gaps in knowledge to support further research 
efforts.   
This review exercise describing the epidemiology of the disease and its key aspects has been 
undertaken in two commissioned editorials in peer-reviewed journals (Brooks et al, 2012; 
Ramirez-Rubio et al, 2013a) annexed in this document, and as a chapter of a technical report 
(Brooks & Ramirez-Rubio, in Wesseling, 2013). Extracts and paragraphs of those documents 
can be found in this chapter. 
4.2 Methods 
A comprehensive literature search in PubMed and Google scholar was conducted in order to 
identify articles related to MeN/CKDu in Central America. Inclusion criteria included: 
 Papers with an explicit mention to an epidemic of CKD of unknown causes or non-
traditional causes; 
 All study designs and/or methods; 
 All Mesoamerican/Central American countries/contexts; 
 Papers published in any year, until June 2013. 
 Papers published in English, Spanish or Portuguese. 
Also, results include official government data (such as mortality rates due to CKD in Central 
American countries) to further illustrate and describe this epidemic. Generally, data from non-
online grey literature was not systematically searched for extraction this time, but has been 
part of our efforts in the past (Brooks et al, 2009), and information from specific reports have 
been included. 
Some of the key words used included chronic kidney disease, chronic renal failure, kidney 
disease, end stage renal disease, proteinuria, glomerular filtration rate, creatinine, AND 
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prevalence, mortality, screening, prevention, treatment, complications, risk factors,  AND 
developing countries, Latin America, Central America, in relation to CKD. 
4.3 Results 
4.3.1 Extent of the problem 
Reports (sometimes anecdotic; i.e. an article in a newspaper) of excess cases of CKDu are 
concentrated in the Pacific coast lowlands to the west of the mountain range that extends 
throughout Southern Mexico and Central American countries (see figure 4.1). El Salvador, 
Nicaragua and north-west Costa Rica are the regions with far more information, including 
prevalence studies published in peer-reviewed journals and mortality data disaggregated by 
sex, age or geographical divisions (departments, provinces, etc). Incidence data is lacking in the 
region. 
Figure 4.1- Map of reported unusual number of cases of CKD. 
 
Source: Ramírez-Rubio,O  & Amador, J.J. 2012 
 
Since cases seem to concentrate in certain geographical areas (eg. CKD prevalence is high in 
communities of the Northwest departments of Nicaragua but not in Managua, despite having 
being actively studied in both places), CKDu would be described in this document as an 
epidemic or a cluster, since cases seem to aggregate at least in place (not known in time), and 
they are suspected to be greater than the number expected, even though the expected 
number, and the population’s baseline is not known (CDC, 2006). 
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4.3.2 Mortality statistics 
Mortality data is the only nationally based system of surveillance for CKD. Furthermore, to the 
extent that the case fatality rate for CKD is high, it serves as a lagging indicator for incidence. 
For example, Tonelli et al (2006) in a meta-analysis that included 39 cohort studies or survival 
analyses of randomized, controlled trials with patients stages I-IV, calculated the predicted risk 
for death during the median follow-up of 4.9 years in 25% (95% CI 17 to 35) for a GFR = 40 
ml/min.  The overall number of deaths due to MeN/CKDu in Mesoamerica as a whole or in any 
of the individual countries is uncertain, primarily because nobody has attempted to estimate 
what percentage of deaths from CKD could be classified as CKDu, a figure that likely varies 
substantially by country.  However, El Salvador has the highest overall mortality rate from 
kidney disease in the world with 51.8 deaths per 100,000. Nicaragua and Honduras are also 
included in the top 10 countries with highest kidney mortality worldwide (25.5 and 24.6 deaths 
per 100,000 respectively) (WHO, 2008), and CKD appears as the second leading cause of 
mortality among men of working age in El Salvador (El Salvador MoH, 2009). 
Mortality figures also show how the epidemic seems to concentrate in certain regions within 
countries. In Costa Rica, the Northwest province of Guanacaste appears to be the main region 
affected (Cerdas, 2005). In El Salvador, most CKD cases in the end stage of the disease referred 
to a national hospital in the capital city came from coastal areas of the country (Garcia-
Trabanino, 2002). In Nicaragua, mortality due to kidney disease during 2009-2011 was almost 
9 times as high in León and Chinandega as the median mortality rate in the country (11 deaths 
per 100,000), and more than twice as high as the rate in Granada, the next highest department 
(Figure 4.2).  On the other hand, other regions of the country, such as in the east, do not 
appear to be affected. Mortality due to kidney disease in León and Chinandega has also 
increased over time, increasing twofold between 2000-2009 (Figure 4.3).  Mortality data at the 
municipal level indicates that Chichigalpa (Chinandega department, sugar cane area) and 
Larreynaga (León department, mining area) have similar rates of mortality and are the highest 
in Nicaragua. In Chichigalpa, one out of every four deaths was due to CKD (personal 
communication with Torres C, 2009). 
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Figure 4.2. CKD mortality rate (x 100,000), Nicaragua, 2009-2011 
 
Source: Nicaragua Ministry of Health. Dirección General de Planificación y Desarrollo. Oficina Nacional de 
Estadísticas. 
Figure 4.3-  CKD mortality rate (x100,000), Nicaragua 2001 - 2009 
 
Source: Nicaragua Ministry of Health. Dirección General de Planificación y Desarrollo. Oficina Nacional de 
Estadísticas. 
 
 
The mortality rate among men is much higher than among women. In 2002, the male:female 
ratio across the whole country was approximately 4:1 (Figure 4.4). In León and Chinandega, 
the male:female ratio was approximately 6:1, while there was little or no male excess in many 
other departments with low mortality rates from CKD. Departments with a male excess tend to 
be in the Pacific region. Although mortality rates among women were much lower than in 
men, in 2002 rates for women were still highest in León and Chinandega, and were also 
elevated in Granada and Rivas, all departments in the Pacific region. 
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Figure 4.4- CKD mortality rates by sex and departments in Nicaragua (2002). 
 
Source: Nicaragua Ministry of Health. Dirección General de Planificación y Desarrollo. Oficina Nacional de 
Estadísticas. 
 
Another key demographic characteristic of the epidemic is the young age at which victims are 
affected. In Chichigalpa, for example, deaths were concentrated in young-middle age groups 
among men, while female deaths did not show a particular pattern (Figure 4.5). 
Figure 4.5 Distribution of CKD deaths (1988-2007) in Chichigalpa (Nicaragua) by sex and age. 
 
Source: Narváez-Caballero & Morales-Mairena, 2008. 
 
4.3.3 Prevalence data and key risk factors investigated 
There have been a number of studies (most of them unpublished) conducted in Nicaragua and 
other Central American countries in the past ten years. For a more exhaustive list, one can 
access reviews by Cuadra et al (2006) and Brooks et al (2009).  Some of these studies were 
carried out using proteinuria measured by dipstick as a measure of kidney damage. However, 
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as diabetes and hypertension are unlikely to be important causes of CKDu in Mesoamerica, 
measures of glomerular proteinuria may be less informative. Nevertheless, virtually all of these 
studies detected elevated rates of proteinuria (mostly in the microalbuminuria range).  The 
study conducted by Dominguez and colleagues (2003) is of particular interest because it is the 
only study to our knowledge that has produced prevalence estimates in certain communities 
of Mexico, Guatemala, and Honduras (El Salvador was also included).  40 % of the men in the 
coastal areas showed some degree of proteinuria, compared to 14% of women in the coastal 
areas and 10% of men living at >500 masl. 28% of men with proteinuria living in the coastal 
zone were <45 years old, and only 12% of them reported pre-existing hypertension or 
diabetes. 
As mentioned before, CKDu/MeN seems to follow a cluster pattern. For example, the Pan-
American Health Organization (PAHO) sponsored a study that was conducted in the city of 
Managua (only 125 km away of Chichigalpa, one of the hotspots of the epidemic in Nicaragua) 
in 2003 to assess prevalence of and risk factors for chronic disease, particularly diabetes and 
hypertension, but included a serum creatinine test at the request of the Ministry of Health. A 
total of 1,704 respondents (85% response rate) were randomly selected using a stratified 
neighborhood sampling plan.  Less than 1% of subjects between the ages of 20-59 had eGFR 
values <60ml/min per 1.73m2, and there were no differences in prevalence between males 
and females [J Amador, unpublished data]. 
Table 4.1 summarizes prevalence studies published in the peer-reviewed literature. All studies 
analyzed serum creatinine and reported the GFR. In addition, they all assessed medical, 
occupational, environmental and behavioral risk factors by questionnaire. Four main 
conclusions have emerged from these studies (Brooks et al, 2012):   
1. There are clear differences in risk of CKD according to type of industry and occupation.  
Workers in the sugarcane cultivation, mining, and fishing or shipping industries have 
higher prevalence rates, while areas in which coffee growing and services dominated 
show no evidence of excess disease.  
2. Persons living at low altitudes are more likely to have CKD than those living at higher 
elevations. Peraza et al (2012) have demonstrated how this pattern persisted even 
when comparing two sugar cane communities at different sea levels.  
3. Males appear to be much more affected than women. Women, although less affected, 
follow also the same distribution as men (i.e higher prevalence’s in low altitude 
communities and higher risk with long term exposure to coastal sugar or cotton 
plantation work). According to Peraza et al (2012) adjusted OR for 10 years increments 
of time performing this work was 3.1 (95% CI 2.0-5.0) and 2.3 (95% CI 1.4-3.7) for men 
and women, respectively.  
4. Age groups affected by CKD are much younger than the age distribution that one 
would expect for a chronic disease. To illustrate this point, O´Donnell et al (2011) 
compared the distribution of eGFR among age and sex groups in Quezalguaque (a 
municipality located in León, Nicaragua) with the same groups in the USA based on 
data from NHANES (Figure 4.6). The overall prevalence of decreased eGFR was 1.8 
times greater in Quezalguaque. However, the relative differences were much greater 
at younger ages: men ages 30–41 in Quezalguaque had rates 16 times as high and also 
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were much more likely to have Stage 4 disease compared to their counterparts in the 
USA. Women in Quezalguaque also had elevated age-specific prevalence compared to 
women in the USA, but the differences were much more modest. 
 
Figure 4.6- Prevalence of kidney disease in Quezalguaque compared with the USA using the 
NHANES 1999–2006 data 
 
 
Source: Adapted from O´Donnell et al. (2011). 
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Table 4.1- Summary of regional community-based studies of chronic kidney disease that used serum creatinine and eGFR as disease estimates  
Locale(s) Studied Occupation* N Altitude† Prevalence and Population Risk Factors 
El Salvador: 
2 Communities 
Jiquilisco, Usulután and 
Sesori, San Miguel 
(García-Trabanino, 2005) 
Agriculture 
291 Low 
 Study included men only  
 Sampling pattern only tested 
serum creatinine in male 
coastline residents with 1+ or 
greater proteinuria 
 Dipstick proteinuria (1+ or greater) noted in 46% 
in low altitude coastal community vs. 13% in 
high-altitude inland community 
 37 of 80 men with lab measurements had 
creatinine>1.5 mg/dL; of these 37, 81% had 1+ 
proteinuria and only 19% 2+ or greater 
proteinuria 
62 High 
      
Nicaragua:  
9 Communities of 
León (Telica, Malpaisillo, 
León), and Chinandega (El 
Viejo, Corinto, Posoltega, El 
Realejo, Chichigalpa, 
Somotillo) 
(Sanoff, 2010) 
Varied 997 
Not stated in 
article but likely 
varied 
elevations 
 Only in men (after too few cases 
found in women) 
 12.4% of population with eGFR 
<60 ml/min/1.73 m2 
 Agricultural field labor, consumption of “lija” 
(alcohol available in a form susceptible to 
contamination by toxins), and consumption of 
>5L of water per day independently associated 
with presence of reduced eGFR 
 Hypertension and diabetes not more common in 
CKD 
      
Nicaragua:  
5 Communities 
León and Chinandega 
(Torres, 2010) 
Subsistence 
Farming + Mining 
445 Low 
 High prevalence of reduced 
eGFR <60 ml/min/1.73 m2), with 
14% of men but only 3% of 
women  
 Abnormal creatinine levels in 31% 
and 24% of male and female 
agricultural workers, respectively, 
at 100-300 m above sea level, but 
not occurring at higher altitudes 
 Abnormal creatinine levels not common in higher 
altitude village (i.e coffee) and services village 
 Banana/sugarcane independently associated 
with higher creatinine in men and 
mining/subsistence farming independently 
associated in both men and women 
 High self reported use of NSAIDs and history of 
UTI, not associated with decreased kidney 
function in the multivariate analysis 
Banana/Sugar 384 Low 
Fishing 216 Low 
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Services 140 Low 
Coffee 92 High 
      
El Salvador: 
BajoLempa region 
(Orantes, 2011) 
Agriculture 775 Low  eGFR<60 ml/min/1.73 m2 in 17% 
of men vs 4% of women 
 Non-steroidal anti-inflammatory drug use 
common  
 44% respondents reported renal disease, but 
40% of those cited UTIs 
 Most affected individuals with neither diabetes 
nor hypertension 
      
Nicaragua: 
Quezalguaque, León 
(O´Donnell 2011) 
Inland 
Varied, 
agriculture 
771 Mostly Low  
 High prevalence of reduced 
eGFR, (<60 ml/min per 1.73m2), 
20% of men vs 8% of women 
 13.4% of men age 30-41 with low 
eGFR 
 Residence at lower altitude (<500 m) associated 
with lower eGFR 
      
Nicaragua: 
Matagalpa 
(Laux, 2012) 
Coffee 267 Very High 
 Very low prevalence (0,7%)of 
reduced eGFR, with no 
individuals below 40 years old 
having reduced eGFR 
 
      
El Salvador: 
5 Communities 
(Peraza, 2012) 
Sugar 129 Low 
 High overall prevalence of 
reduced eGFR 
 Discrepant findings in sugar communities with 
eGFR below 60 ml/min per 1.73m2 common 
(18% of men) at low altitude sugar communities 
but rare (0-2%) in the high altitude sugar 
community;  
 Women less affected than men but following the 
same pattern (8% in low altitude sugar cane vs 
1-3% in other communities) 
 Proteinuria uncommon and low-grade 
Sugar/Services 159 Low 
Sugar 120 High 
Coffee 124 Very High 
Urban Services 132 High 
      
Source: adapted from Weiner et al, 2012.
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4.3.4 Follow-up studies 
There has been only one follow-up study in the region that investigates MeN/CKDu. This study, 
yet unpublished and conducted by our group (McClean et al, 2012), assessed the renal 
function during the 6-months harvest period of 2010-2011 of 284 sugar cane workers 
contracted for different job tasks (cane cutting, seed cutting, seed planting, irrigating, pesticide 
application, drivers and factory workers). Miners, port and construction workers kidney 
function was also assessed with only one point in time measures. Kidney damage markers, 
such as serum creatinine and glucose, urinary albumin, NGAL, NAG and IL-18, were measured. 
This study also assessed heavy metals exposure in a subsample of these pre-post harvest 
paired samples (blood lead concentrations, and urinary cadmium, total arsenic and uranium).  
Results from linear regressions showed a significant decrease during the harvest of the 
estimated Glomerular Filtration Rate (eGFR) in those job categories that involve more 
strenuous tasks and are most exposed to heat, namely cane (p = 0.006), and seed cutters (p = 
0, 03), along with significant increases in the levels of NAG, NGAL and IL-18. Decreased kidney 
function was prevalent in the non-sugar cane workers when compared to US prevalence. 
Albuminuria and glycosuria, however, were minimal in all the job categories.  
On the other hand, overall concentrations of lead, cadmium, arsenic and uranium levels did 
not exceed international exposure standards, did not increase significantly during the harvest 
and there were no significant differences between the different job categories. Furthermore, 
levels of lead, cadmium and uranium were not associated with any biomarker of kidney 
damage or kidney function. Concentrations of total arsenic in urine exceeded WHO’s guideline 
of 100 μg/L for 3 workers out of 99 sampled. Though there were not significant differences in 
urinary arsenic by job category, workers with the highest arsenic exposures (above the 90th 
percentile) were found to have significantly higher serum creatinine (p=0.04) and significantly 
lower eGFR (p=0.01), while controlling for age and sex. The fact that the inorganic fraction of 
arsenic, which is the most nephrotoxic, was not measured makes it difficult to conclude 
whether arsenic may be associated with kidney damage in this context.  
 
4.3.5 Biopsies 
There is only one published report of a series of biopsies on CKDu/MeN patients. Wijkström 
and colleagues (2013, on press) performed light microscopy, immunofluorescence, and 
electron microscopy examinations on 8 male patients that used to work on plantations in EL 
Salvador with estimated glomerular filtration rates from 27 to 79 mL/min/1.73 m2. They found 
a similar pattern in all 8 biopsy specimens, consisting on extensive glomerulosclerosis (29%-
78%) and signs of chronic glomerular ischemia in combination with tubular atrophy and 
interstitial fibrosis, but only mild vascular lesions. The electron microscopy indicated podocytic 
injury, and among other findings were no or low-grade albuminuria, normal blood pressure, no 
diabetes, frequent use of NSAIDs, increased levels of tubular injury biomarkers, and 
hypokalemia (in 6 of 8 patients). The authors were surprised by the presence of relatively 
extensive glomerular sclerosis, but preserved glomeruli and no vascular changes; and argue 
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whether those changes might be a sequelae of dehydration and NSAIDs intake, with 
subsequent activation of the renin-angiotensin-aldosterone system. 
 
4.3.6 Causal hypotheses 
Risk factors emerging from the mentioned studies, and well known environmental causes of 
CKD thought to play a role in this epidemic, have served researchers to build up a list of 
potential causes of CKDu/MeN. Researchers at the SALTRA workshop in Costa Rica (November 
2012), convened to prioritize the different hypotheses (see table 4.2) based on the level of 
evidence and plausibility gathered to date, as well as their feasibility for being studied 
(Wesseling et al, 2013).  
Table 4.2-Proposed Priorities for Exploring Hypotheses for Causes of MeN  
Source: Wesseling et al, 2013. 
This section does not intend to dig into each of the causal hypotheses proposed to date, but to 
provide an overview of the main ones being considered to date. Brief concept papers written 
by several researchers for each of the causal hypotheses have been included in the SALTRA 
report (Wesseling et al, 2013). While some factors are well-known causes of CKD (e.g. heavy 
metals), others still require the development of new biological pathways to be tested in 
experimental and observational studies (e.g. heat exposure). All together, they constitute a 
complex map of causal hypotheses. A proposed causal web by Ramirez-Rubio et al. (2013b) 
can be found in the next chapter. Furthermore, CKD development in this context may require 
that two or more factors are present (e.g. heat exposure + NSAIDs, fructose intake or 
agrichemical use). Indeed, connections between the different risk factors (susceptibility, 
initiation and/or progression), proposed because of its biological plausibility and/or its 
association with CKDu in the different prevalence and case control studies to date, have 
brought researchers to think that etiology is presumably multifactorial, with multiple insults to 
Highly Likely, High Priority to Investigate Further 
Heat stress and dehydration (including electrolyte imbalances) 
Non-steroidal anti-inflammatory drugs (NSAIDS) 
Possible, High Priority to Investigate Further 
Arsenic 
Fructose intake 
Nephrotoxic medications, including homeopathic medications 
Leptospirosis and other endemic infections 
Possible, High Priority but Logistically Difficult at this Time 
Genetic susceptibility and epigenetics 
Low birth weight and other prenatal, perinatal, and childhood exposures that increase susceptibility 
Unlikely but strongly believed, Medium Priority to Investigate Further 
Pesticides 
Urinary tract diseases and sexually transmitted diseases (STDs) 
Little Information, Medium Priority to Investigate Further 
Calcium in drinking water, or water ‘hardness’ 
Medication contamination and use of homeopathic medicines and non-approved drugs 
Unlikely, Low Priority for Further Investigation 
Lead 
Mercury 
Cadmium 
Uranium 
Aristolochic acid 
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kidney damage being responsible of kidney function deterioration over time. Even more, 
susceptibility factors may be distributed along the life-course including childhood, with 
initiation and/or progression factors playing a role during adulthood, particularly during 
occupational exposures (Ramirez-Rubio et al, 2013a; Wesseling et al, 2013).  
In any case, most speculated scenarios would involve the same mechanism: repeated 
subclinical insults to the kidney or overt acute kidney injury (AKI) episodes leading to CKD.  
Although it generally had been held that AKI leads to CKD only in the absence of functional 
recovery from the initial injury, recent evidence suggests that residual subclinical damage may 
increase the risk of CKD (Coca et al, 2007; Venkatachalam et al, 2010; Coca et al, 2012).  
Figure 4.7 Causal hypotheses of CKDu/MeN 
 
Source: Image from a YouTube video titled “CAO Case in Nicaragua: Collaborative research on Chronic Kidney 
Disease by Boston University”. Available at: http://www.youtube.com/watch?v=DAll0C9Ax_E 
Given the tropical climate and challenging working conditions in the region, investigators have 
proposed volume depletion and heat stress as one of the main potential mechanisms for CKD 
in the region (Brooks et al, 2012; Wesseling et al, 2013). Altitude appeared in the different 
prevalent studies as an important factor to take into account (i.e. higher prevalence rates have 
been found at communities laying in lower altitudes). It is unclear whether the association 
between altitude and decreased kidney function represents a direct effect of altitude, as 
suggested elsewhere due to the hypoxia mechanisms damaging the renal tubules (Ghahramani 
et al, 2011), or to the particular distribution of environmental (e.g. water quality, heavy metals, 
infectious diseases) and/or occupational exposures (e.g. heat, agrichemicals).  So far, altitude 
has been mainly considered a proxy to detect differences in temperature and weather 
conditions between the lowlands (hot and humid) and highlands (a little bit cooler) in this 
region, although this fact needs confirmation. Also, it is unclear whether the ambient 
temperature in Mesoamerica has increased over time due to global warming. Given the nature 
of the work (strenuous physical activity under very hot temperatures), witnessed by our group 
during an industrial-hygiene and occupational health assessment in 2010 (McClean et al, 
2011), as well as other investigators (Crowe et al 2009; Delgado Cortez, 2009), performed by 
workers that showed an increased risk of kidney damage, investigators have postulated that a 
chronic state of dehydration plus muscle damage leaves individuals susceptible to 
accumulation of damage to the kidneys from repeated subclinical insults, which eventually 
develops into CKD. Along these lines, hydration and re-hydration practices deserve also further 
attention. For example, Johnson and colleagues are studying whether the combination of 
50 
 
dehydration eventually coupled with hydration with fructose enriched fluids, may result in 
increased fructose levels in the proximal tubules which may further damage proximal tubular cells 
(Wesseling et al, 2013, pp117-118). 
With regard to heavy metals, there are documented chronic renal effects in humans from exposure 
to arsenic, lead, cadmium and mercury. In the context of CKDu/MeN, arsenic accumulates more 
evidence than the rest so far. As Laws & Amador explain in the SALTRA report (Wesseling et al, 
2013) many of wells sampled in Telica, a municipality of Leon (Nicaragua) had arsenic levels 
exceeding the WHO exposure guidelines, and there is evidence of human exposure of arsenic-
induced skin lesions in near-by communities. Finally, as noted above, high arsenic levels were also 
found to be associated with decreased kidney function among workers sampled by Boston 
University (McClean et al, 2012). 
NSAIDS and other nephrotoxic medication intake are a key factor that may play an important role 
in a multifactorial causality web. They are widely available without prescription, but also commonly 
prescribed for urinary symptoms that may have a relationship with dehydration, as will be 
described in the next chapter (Ramirez-Rubio et al, 2013b).  
Agrochemicals are extensively used in the region. Particularly, organophosphate and 
organochloride (highly used in the 80s) exposure has been found in the general population in 
breast-milk and blood (CIRA, 1997; Azaroff, 1999). Some of the current used agrichemicals (such as 
2, 4-D, glyphosate, etc) have shown some evidence of kidney damage (but not CKD) in the 
literature (McClean et al, 2011). Evidence against this hypothesis are that the facts that CKD does 
not appear as prevalent in high altitude agricultural communities when compared to low altitude 
ones (although similar cultural practice and agrichemicals are used), and that high frequency of 
reduced eGFR has been found as well in occupations with no exposure to agrichemicals (miners, 
stevedores and construction workers). Nevertheless, this evidence is not enough to conclude that 
agrochemicals are not playing a role in this epidemic, being a hypothesis that deserves further 
attention. Furthermore, pesticides exposure is believed to be the primary cause of CKDu/MeN by 
most of the affected population, as well as many public health officials and researchers (as per an 
interview with El Salvador Minister of Health;  Conner Gorry, 2013), and its use in the region is 
surrounded by safety issues concerns, that probably deserve immediate actions (whether or not 
they are related to CKDu/MeN).  
Finally, infection by leptospira, is another interesting hypotheses to be considered. Leptospirosis is 
an emerging infectious disease and an occupational hazard for people who work outdoors, 
including sugar-cane field workers (WHO, 2003); plus high seroprevalence of leptospirosis has been 
described in northwestern Nicaragua (Ashford et al, 2000). Manifestations of leptospirosis range 
from subclinical infection to severe disease accompanied by acute kidney failure. To date, there has 
been little research regarding the potential for leptospirosis infection to cause chronic tubular 
dysfunction or CKD in the absence of severe and hemorrhagic acute illness (Daher et al, 2004; 
Cerqueira et al, 2008; Ganoza, et al 2010). Presently, we are studying in collaboration with the 
Centers of Disease Control (CDC, USA) leptospira infection (acute and chronic) in the urine and 
blood samples provided by the longitudinal workers study mentioned above (McClean et al, 2012). 
The following table 4.3 provides the strengths and weaknesses of the different causal hypotheses 
based on the general knowledge and scientific evidence generated to date (Weiner et al, 2012). 
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Table 4.3- Potential Causes of Endemic CKD in Central America  
Possible Causes Supporting Data Opposing Data 
Toxins   
Agrichemicals  Extensively used in the region 
 High rates of morbidity and mortality documented 
in areas with high proportion of agricultural 
workers  
 With high volume of water intake, low 
concentrations of toxins still may yield high kidney 
exposure  
 High organophosphate exposure in El Salvador 
agricultural communities 
 No single agrichemical linked to tubulointerstitial kidney disease without 
significant other organ involvement 
 Similar agrichemicals used at higher altitudes but CKD does not appear highly 
prevalent 
 High frequency of reduced eGFR found in occupations with no exposure to 
agrichemicals: miners, stevedores, construction workers  
Heavy Metals  Typically manifests with indolent tubulointerstitial 
nephritis 
 Lack of sophisticated water delivery systems 
 Active volcanic region 
 Arsenic common in water and soil in the region  
 With high volume of water intake, low 
concentrations of toxins still may yield high kidney 
exposure  
 Association between high urinary arsenic levels 
and low eGFR levels among tested workers 
 Limited evidence of high water levels of heavy metals, including cadmium, 
lead, arsenic, uranium and 10 others in water samples tested once in 
Chichigalpa, 2010  
 No evidence of high urinary levels of cadmium, lead, or uranium or any 
association between these metals and reduced eGFR among tested workers  
 Male predilection 
Aristolochic Acid  Clinical course and manifestations consistent with 
Balkan endemic nephropathy 
 Multiple species of Aristolochia present in 
Nicaragua and used for herbal remedies 
 Male predilection 
 No reported increased risk of genitourinary tract malignancies 
 No data regarding use of herbal remedies containing Aristolochia in epidemic 
areas 
Medications  Wide, poorly regulated availability of antibiotics, 
including aminoglycosides  
 Extensive use of non-steroidal anti-inflammatory 
drugs  
 May predispose to kidney failure in the setting of 
other toxins 
 Unusual cause of chronic kidney disease at the population level in the 
absence of other factors, particularly in otherwise healthy individuals 
Infections   
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Leptospirosis  Extremely common in this region 
 Associated with acute kidney injury 
 High seroprevalence 
 Agricultural workers known to be a high-risk group 
 Insufficient number of diagnosed cases to account for epidemic; prevalence 
of a chronic carrier state unknown 
 Acute, severe disease not subtle 
 Uncertain link to CKD unless via acute kidney injury 
Pyelonephritis  Pyuria and genitourinary symptoms common in 
local population, including men 
 Urine cultures in the setting of leukocyte esterase positivity or 
 symptoms showed no growth in all 50 male workers tested, 
 whereas 3 of 11 female workers had positive cultures  
EpiGenetics/Developmental 
susceptibility 
 Low birth weight (and therefore low nephron 
mass) fairly common 
 Recognized CKD anecdotally more common in 
persons with greater indigenous ancestry 
 Genes associated with protection against tropical 
diseases seem to increase the risk of CKD among 
persons with African ancestry allelic variation, 
including Hispanic populations  
 On clinically performed ultrasonography, no evidence of systemic 
developmental or anatomic abnormalities 
 Nothing is known about the genetic admixture of the local population nor 
the prevalence of alleles that have been shown to be associated with an 
increased risk of CKD 
 Greater indigenous ancestry associated with lower 
 socioeconomic status, which is a risk factor for CKD in other 
populations 
Volume depletion, heat-related  Low altitude Western Nicaragua is hot and humid, 
and is considered the hottest region in Nicaragua 
 CKD more common among workers engaged in 
heavy manual labor, typically consisting of men 
 CKD more common at lower altitudes 
 Heat-associated acute kidney injury is not common in high income countries 
and, when present, tends to manifest coincident with multi-organ organ 
injury 
 Requires that acute kidney injury, either recognized or subclinical, be the 
cause of CKD 
 No documentation of frequent episodes of clinically recognized AKI caused 
by heat-related causes 
Source: adapted from Weiner, 2012 
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4.4 Discussion  
Mortality and prevalence data available indicates that CKD is among the most common causes of death 
in some Central American countries, and most important, CKDu/MeN cases are not distributed equally 
along sex, age, geographic regions, altitude and occupational groups.  
As described above, epidemiological information about CKDu is still very limited. There are as yet no 
official or unofficial estimates of the numbers of new cases of CKDu, people living with the disease, or 
deaths attributable specifically to CKDu in Mesoamerica.  The available information is based mainly on 
records of deaths attributable to CKD and a few community prevalence studies. For the most part, these 
studies have been conducted in areas where large numbers of cases of CKD have been reported; the 
extent of disease in other areas is not well understood. The fact that big companies in the agriculture or 
mining sector are conducting active screening programs prior to hire workers is contributing to identify 
cases and hotspots of the epidemic, facilitating to identify the causes attributed to a particular death, 
especially  in poor and rural areas, or simply CKD cases that otherwise would go undiagnosed. It is not 
know whether in places where there has not been such an active screening linked to research projects 
or occupational health programs, cases may stay unrecognized, due to the lack of symptoms in early 
stages of CKD, the slow progression and the few clinical manifestations until kidney failure and uremia is 
present. Even more, these reasons also apply to explain why this epidemic is either occurring now or, if 
it has been going on for some time, just being recognized now. Critically, several Central American 
countries underwent conflicts and wars until a couple of decades ago, with life expectancy, sanitation 
and available health care increasing in the past years dramatically, which would have set up the 
conditions for a chronic disease to show as a prevalent one.  
Nevertheless, there is variation in the extent of ascertainment of mortality data at national Ministries of 
Health by country within Mesoamerica.  One study in the municipality of Chichigalpa (Nicaragua) 
compared the availability of mortality data from the national ministry of health register with the civil 
registration at the municipality, and found that 21% of deaths in the latter were not recorded in the 
national register (Narváez-Caballero et al, 2008).  The benefit of relying on mortality data depends on 
the absence of substantial bias by geography, occupation, sex, and age in extent of reporting of death 
certificates or attribution bias in cause of death. However, to our knowledge, no studies have assessed 
the potential for bias. 
The community- prevalence studies listed also present a number of limitations that result primarily from 
a lack of resources and have been described in earlier reviews (Cuadra et al, 2006; Brooks et al, 2010).  
One limitation common to all studies was that creatinine was tested only at a single point in time.  
Because the case definition for CKD requires two consecutive GFR values <60ml/min per 1.73m2, a 
single measurement overestimates the prevalence, but there is little information on its magnitude 
(Bottomley et al, 2011; de Lusignan et al, 2011). It should be noted that the U.S. National Health and 
Nutrition Examination Survey (NHANES), which serves as the primary source for prevalence of reduced 
GFR in the U.S. population, likewise uses only a single measurement; therefore, comparisons of 
prevalence in Mesoamerica with those in the United States are based on the same testing frequency. All 
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studies listed in the table used the Modification of Diet in Renal Disease (MDRD) study equation. 
However, in a community-based study where the great majority of subjects will have eGFR≥60ml/min 
per 1.73m2, the CKD-EPI equation appears to be more accurate (Stevens et al, 2010). Limitations also 
include the cross-sectional design (i.e. reliance on prevalent rather than incident cases), and the strong 
questionnaire-based assessments. With few exceptions, data on risk factors have been collected 
exclusively by questionnaire instead of environmental or biological testing, with potential for exposure 
misclassification in general and recall bias in particular (e.g. agrichemical use).  Furthermore, questions 
have not been validated, nor have they been standardized across research groups and there is a lack of 
information on quality control measures.  
Nevertheless, prevalence studies to date have served an important role in moving beyond mortality 
data, providing additional quantification to the magnitude and regional variation of MEN, and adding 
evidence for certain hypotheses about the causes of MEN/CKDu.  
Further efforts should prioritize active surveillance of CKD incidence, its social and demographic 
determinants at the population level. Strengthened surveillance systems capable of monitor new cases 
arising from the clinical practice and current active surveillance systems in workplaces and research 
interventions are needed. As part of this effort, a consensus around a case definition of this particular 
presentation of CKD is also needed. This would benefit efforts to determine cause(s) of MEN, as well as 
provide information on whether the rate of cases is increasing, stable, or decreasing, which would be 
important for public health planning and evaluation of interventions. To date, data on the incidence of 
CKD are lacking since it is not usually included in the set of diseases included in surveillance systems in 
the region, which are focused almost exclusively on infectious diseases. Also, systematic data on the 
natural history of the disease are also lacking, such as time between early injury and occurrence of 
disease, latency time from occurrence to diagnosis, and survival time from diagnosis to death. A better 
understanding of these components might help focus on certain hypotheses by providing a framework 
for timing of exposure, along with an understanding of factors that might slow the progression of the 
disease. 
In addition, research priorities to address gaps in knowledge include: 1) Prevalence studies in additional 
areas selected on a systematic basis, 2) Longitudinal studies capable of assessing incidence and 
progression, 3) Burden of disease studies, quality of life, and social determinants of the disease (social 
inequalities and poverty).  
Taken together, strong advances have occurred in the past few years with Central American Ministries 
of Health and the Pan American Health Organization recognizing MeN/CKDu as a regional public health 
priority, and research projects taking place; but there is still a significant task to identify the causes of 
this puzzling epidemic and devoting enough resources to prevent, diagnose and treat the disease in a 
time manner. 
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CHAPTER V: HEALTH PROFESSIONALS’ 
PERCEPTIONS AND BELIEFS REGARDING 
ETIOLOGY OF MeN/CKDu AND RELATED 
CONDITIONS, AND THEIR TREATMENT 
APPROACHES  
“I want to understand the world from your point of view. I want to know what you know in the way you know it. I 
want to understand the meaning of your experience, to walk in your shoes, to feel things as you feel them, to 
explain things as you explain them. Will you become my teacher and help me understand?”  
― James P. Spradley  
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5.1. Introduction  
 
Chronic kidney disease (CKD) is a serious and increasing global health problem. Treatment for its most 
severe form, end stage renal disease, with dialysis or transplant is currently not available in many parts 
of the world (Levey et al, 2007; Moeller et al, 2002). Major known risk factors for CKD include diabetes 
and hypertension (Lea et al, 2002; Ejerblad et al, 2006). However, in lower income countries CKD may be 
associated with chronic glomerulonephritis and interstitial nephritis, which are generally ascribed to 
infectious and parasitic agents (Soderland et al, 2010). In Central America, case reports and government 
statistics document high mortality due to CKD, particularly among younger men and in certain regions of 
the Pacific coast (Garcia-Trabanino, 2002; Cerdas, 2005; Cuadra et al, 2006). Community prevalence 
studies in Nicaragua and El Salvador are consistent with these mortality data and have attempted to 
assess associations with pharmaceutical, behavioral, environmental and occupational exposures (Garcia-
Trabanino, 2005; Torres et al, 2010; Sanoff et al, 2010; Laux, 2011 et al; O'Donnell et al, 2011; Orantes et 
al, 2011; Peraza et al, 2012). However, the causes of the high prevalence of CKD remain unknown.  
 
Our team has been working in northwestern Nicaragua since 2009 as part of a mediation process 
(termed the “Dialogue Table”) including the management of Nicaragua Sugar Estates Limited (NSEL), a 
major sugar producer in northwestern Nicaragua that operates the Ingenio San Antonio located in the 
town of Chichigalpa, and the Association of Chichigalpans for Life (ASOCHIVIDA), a group of 
approximately 2000 former NSEL workers and community members who are affected by CKD. The 
Dialogue Table was established in 2008 after ASOCHIVIDA filed a complaint with the Compliance Advisor 
Ombudsman (CAO), the independent office that handles complaints from communities against the 
World Bank Group's private sector arm which had provided funding to NSEL. CAO formed the Dialogue 
Table in response to the complaint, and the participants determined that they wanted an outside 
scientific group to make an independent assessment of the epidemic. Our team led by the Boston 
University School of Public Health was selected by Dialogue Table participants.  
 
Our research occurred in stages, beginning with a “scoping study” summarizing the available 
information on CKD in the region, identifying data gaps, and recommending research activities to 
address those gaps (Brooks et al, 2009). During the process of conducting the scoping study we learned 
from members of the Dialogue Table and from informal discussions with area physicians of the frequent 
occurrence of a set of symptoms referred to locally as “chistata,” characterized by painful urination and 
often accompanied by “kidney” and/or back pain, and the common diagnosis of urinary tract infections 
(UTIs) among young men. Our final list of potential causes was extensive.  We identified several feasible 
activities that would provide more information to evaluate these hypotheses (Brooks et al, 2009, 
McClean et al, 2010).  
 
Among the subsequent research activities, we conducted qualitative interviews in Chinandega and Leon 
(regions with the highest CKD mortality rates in Nicaragua) both with physicians who are likely to 
diagnose or treat chistata, UTI, and/or CKD and with retail pharmacists who are likely to fill prescriptions 
or sell medications to treat these conditions. Medication use was on our list of hypotheses because 
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members of the Dialogue Table reported that use of analgesics, and potentially nephrotoxic antibiotics 
that would require prescriptions in many higher income countries, were common in Nicaragua and 
could be obtained without a prescription. Medications are a common cause of acute kidney injury and 
may be associated with CKD (Sandler et al, 1989). For example, non-steroidal anti-inflammatory drugs 
(NSAIDs) are a frequent cause or contributor to acute kidney failure in the setting of severe volume 
depletion or other nephrotoxins. Aminoglycosides (a class of broad spectrum antibiotics) also are 
common causes of acute kidney failure, with risk factors including preexisting kidney disease, 
concomitant nephrotoxic medication use, and dehydration/volume depletion. 
 
While there had been a great deal of media and activism focused on CKD and potential causes in 
Nicaragua, we did not know the general knowledge, opinion or practice of physicians and pharmacists in 
the region. Our aims in this study were to: (1) increase our understanding of health professionals´ 
perceptions regarding CKD in the region (characteristics of the affected population, causal hypotheses, 
symptoms, diagnostic tools, treatment and prognosis); (2) determine whether further study of the 
relationship among hydration practices, diagnosis of UTI/chistata and use of medications is warranted; 
and (3) explore potential opportunities for public health interventions related to the CKD epidemic 
aimed at physicians and pharmacists. This was the first effort known of by our team to engage 
physicians and pharmacists in Nicaragua in a formal assessment of the CKD epidemic. 
 
5.2. Methods 
Recruitment and interviews were conducted in November 2010. In order to select interviewees, we 
acquired a list of public or government health care institutions from the Ministry of Health and a registry 
of pharmacies in Chinandega and León. We also acquired a list of private health institutions or clinics 
where CKD patients may seek care from the Social Security System. Each of the two regions (Chinandega 
and Leon) contained one main referral hospital, 13 and 16 public health centers, 6 and 4 social security 
or private clinics, and 145 and 212 pharmacies, respectively. We selected physicians from the health 
care institutions in each region so as to achieve a diverse sample with regard to sex, location, type of 
institution, and specialty of physician, and then selected pharmacies based on proximity to the sampled 
health care facilities. We estimated that 10 physicians and 10 pharmacists would be a feasible number 
to interview given time and budget constraints, would be sufficient to reach data saturation (i.e., 
redundancy in results to the point where interviews are not providing new information), and would 
enable us to identify trends and themes in the data.  
 
We prepared an interview guide that consisted of 34 and 24 open-ended questions asked of physicians 
and pharmacists, respectively (available upon request). Open-ended questions asked in qualitative 
studies are typically designed to learn the opinion, beliefs, experience and reported behavior of the 
interviewee without prescribing response options or leading interviewees to a particular answer. We 
developed the interview guide with our hypotheses in mind, to learn from interviewees their opinion 
about the strength of various hypotheses based on their experience, and also to learn from physicians 
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and pharmacists about their own hypotheses, if any, regarding the causes of CKD in the region. We 
began with broad questions such as, “What can you tell me about CKD in Nicaragua?” following up with 
more specific questions such as: “Do you think CKD is a problem in Nicaragua?”, “Has the number of 
cases you see each year changed in the time you have been in practice?” and “How would you describe 
the affected population?” For each major topic, we started with a broad question, “What do you think 
are the causes of CKD in Nicaragua?” and then followed up with specific questions that might indicate 
their opinion of hypothesized causes. Questions asked of both groups addressed the following topics: 1) 
prevalence and causes of CKD in Nicaragua; 2) population most affected; 3) beliefs regarding dysuria-
related symptoms, prevalence of UTI and sexually transmitted infections; and 4) knowledge regarding 
indications and risks associated with use of potentially nephrotoxic medications. Additionally we asked 
physicians about standards and criteria for diagnosis and treatment of CKD and the availability and cost 
of diagnostic tests and medications. Interviews included a series of follow-up questions or probes to 
elicit additional information on these topics if not volunteered. A draft of the physician interview guide 
was tested with a physician in Nicaragua associated with our study team to determine if the length, 
organization and Spanish translation were appropriate. 
 
Interviews were conducted individually and in-person by a native Spanish speaker (ORR). Informed 
consent was obtained at the time of the interview. Ethics approval was obtained both from the 
Institutional Review Board of Boston University Medical Campus and the Nicaraguan Ministry of Health. 
All interviews were electronically recorded, transcribed and translated into English by a professional 
transcription agency and cross-checked for accuracy by the interviewer. All identifiers (i.e., names of 
individuals, locations and names of institutions) were removed from English and Spanish versions of the 
transcripts prior to analysis. To protect anonymity, all research participants are referred to by a 
masculine pronoun regardless of sex. 
 
Interviews were analyzed using standard social science methods for analyzing qualitative data (Patton, 
2002). An initial list of 33 codes (words and phrases used to tag portions of the transcript) was created 
based on the interview questions, which were based on existing hypotheses (Bogdan, 1982). Coding the 
transcripts enables analysts to retrieve codes and associated data and to assign values of frequency, 
presence/absence and relationship with other codes (MacQueen et al, 1998). For example, the code 
“CKDOCC” allowed us to tag and retrieve all text, including positive and negative examples, in which the 
occupation of CKD patients is referred to either in response to the question about the populations that 
are most affected, or in a different part of the interview. Text associated with each code can then 
subsequently be analyzed, and additional codes developed (e.g., OCCAG, to tag more specific mentions 
of agricultural occupation) (Bogdan et al, 1982). Two analysts (MKS, ORR) separately coded the text and 
then together reviewed the codes. After agreement was reached on coded text, each analyst prepared 
summaries of the findings and met again to test agreement. The last step was to organize codes under 
thematic or conceptual headings and to assign meaning to the codes (Bogdan et al, 1982). Specifically, 
we sought to understand how potential causes of the CKD epidemic identified in the interviews 
compared with our pre-existing hypotheses, and how perception of these causes might potentially 
inform future research activities.   
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5.3 Results 
All physicians and pharmacists approached by our team agreed to be interviewed, demonstrating a high 
level of awareness and concern regarding the disease, societal effects and implications for their practice. 
We interviewed ten physicians and nine pharmacists who were diverse with regard to geographic areas 
and locations (Table 5.1). Six of the nine pharmacists reported a degree in Pharmacy and/or Chemistry, 
with three reported no formal training. The results of our analysis are organized by headings that reflect 
key findings of physician and pharmacist opinions, experiences and practices.  
Table 5.1 -Characteristics of interviewees 
  Physicians Pharmacists 
  n=10 n=9 
Sex     
Women 6 (60) 8 (89) 
Men 4 (40) 1 (11) 
Region   
Leon 5 (50) 5 (56) 
Chinandega 5 (50) 4 (44) 
Location   
Rural 6 (60) 6 (67) 
Urban 4 (40) 3 (33) 
Health Institution   
Health Center 7 (70) NA 
Hospital/2nd level health center 3 (30) NA 
Physician Specialty   
General Practitioner 6 (60) NA 
Nephrologist/Internal Medicine 4 (40) NA 
Years of experience 19 (9-30) 10 (1-25) 
Interview length (minutes) 41 (11) 18 (4) 
Results are number (%) for all variables, except median (range) for years of experience and mean (sd) for interview length. NA: 
Not Applicable 
 
5.3.1 CKD: Prevalence, Diagnosis and Prognosis of a serious and increasing 
problem in Nicaragua  
All interviewees stated that CKD is a serious problem. With the exception of one pharmacist, all 
interviewees were of the opinion that the number of CKD cases has increased each year, although four 
physicians suggested that this may be partially explained by improvements in monitoring and diagnoses. 
 
All physicians indicated that the observation of decreased kidney function over time would be the basis 
for the CKD diagnosis. Seven of the ten physicians observed that patients with CKD had no or very little 
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proteinuria. Six physicians relied on serum creatinine to classify a patient with CKD while four also 
calculated estimated glomerular filtration rate. Seven physicians indicated that, while ideal, kidney 
ultrasounds require referral to a hospital or private clinic and are usually not feasible.  In terms of 
treatment, seven of the ten physicians said they do not have access to national or regional guidelines for 
the diagnosis and treatment of CKD and therefore relied on guidelines for other chronic diseases 
(hypertension or diabetes), their own familiarity with CKD, or, in one instance, an “ad hoc” protocol 
developed by local physicians. Three physicians who said they had access to CKD-specific diagnosis and 
treatment guidelines referred to protocol of Nicaragua’s Nephrology Association or the Ministry of 
Health, or international standards published by the National (USA) Kidney Foundation’s Kidney Disease 
Outcomes Quality Initiative. All physicians indicated that patient survival depends on stage of CKD at 
diagnosis, self-care, and nutrition as well as access to dialysis or transplant, neither of which are widely 
available in Nicaragua. 
 
5.3.2 CKD Causes:  Strong sun, hard work, and… water? 
All ten physicians and six of nine pharmacists described men as the most affected population. More than 
half of the physicians volunteered that the causes of the CKD epidemic did not include the traditional 
risk factors of diabetes or hypertension. Four physicians suggested that, while women experience CKD, 
the majority of cases in women can be explained by underlying risk factors. The affected population was 
most often described as under age 45.  
 
Seven of the ten physicians identified agricultural workers (fruit pickers and workers on banana, cotton, 
melon, peanut, rice, and sugar plantations) as most affected by CKD. Eight of nine pharmacists explicitly 
identified what they thought was an occupational association, with one stating: “Those who are not 
diabetic are almost all males who work in the fields.” Other non-agricultural occupations mentioned 
included miners, construction workers and bricklayers.  
 
Nine physicians referred to exposures at work, with seven identifying exposure to sun and heat as the 
major occupational factor associated with CKD. All ten physicians described many possible contributors 
to CKD, with six using the term “multi-factorial.” Chemicals used in agriculture were identified as a 
possible cause by half the physicians, and three talked about contaminated drinking water, with two 
referring specifically to heavy metals.  
 
Water was the common denominator in eight of nine pharmacist responses regarding the causes of 
CKD; however, there were two distinct perspectives on the role of water. Four pharmacists thought that 
insufficient water intake was the primary problem, while four other pharmacists believed that drinking 
contaminated water was the problem. Three of the four pharmacists who thought dehydration was the 
problem also thought it was not the only cause, or else, as one said, “everyone would be dead.” Another 
pharmacist summarized beliefs about causes:  
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“I think that [CKD] is from the dehydration they get in the fields, their work is hard, hard, and 
they ruin themselves taking diuretics and further draining their body water.”  
 
Other causes of CKD mentioned by more than one interviewee (in order of frequency) were the use of 
nephrotoxic medications, alcohol, and poor nutrition. Other possible contributors mentioned included 
leptospira infection and volcanic ash.   
 
5.3.3  “Chistata” and UTI: Physician perspectives on their diagnosis and 
treatment, and associations with CKD 
All physicians said that “chistata” is a colloquial term used to characterize a constellation of symptoms 
including “pain,” “burning” and the “urgent” need to urinate, with chistata approximating the clinical 
term dysuria. Nine physicians opined that dehydration is a probable cause of chistata, while eight also 
cited UTIs. There was disagreement among physicians as to how closely infection was related to 
chistata, with some equating the two, and at least one insisting, “they cannot just be considered 
synonymous.”  
 
When queried further about UTI, four of the ten physicians claimed to diagnose UTI based on the results 
of a urine culture. However, two of these physicians acknowledged that they do not have the facilities to 
analyze a urine culture and, as one stated, it would be “at the cost of the patient.”  Instead, these two 
along with five others admit to diagnosing UTI based on a urine exam indicating the presence of 
leukocytes, bacteriuria and/or nitrites via dipstick when available, under a microscope, or a combination 
of both practices. One physician suggested UTIs are probably over diagnosed: 
 
“What happens is that we have been doing a bad management of the urinary tract infections… 
sometimes we consider that the appearance of white blood cells, leukocytes, in urine is enough. 
But it is not like that.”  
 
When asked about the relationship among chistata, UTI and CKD, seven physicians said that UTIs may be 
associated with CKD. Five thought the connection had to do with repeated, non-treated or inadequately 
treated UTIs and regular use of broad spectrum antibiotics.  
 
There was no agreement regarding the relationship of nephrolithiasis with CKD. Four physicians said 
that stones are not frequent, while six said they are very frequent. Three physicians named kidney 
calculi as a possible cause of chistata, with two associating them with “too concentrated urine” or 
“sandy urine” due to dehydration. 
 
When asked how chistata is treated, seven physicians said they recommend oral rehydration solutions, 
and seven recommended urinary analgesics such as phenazopyridine or the antibiotic nitrofurantoin. 
Five physicians specified that they would not treat chistata without further tests. Antibiotics that they 
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might then prescribe included fluoroquinolones, amoxicillin, and penicillin, with one physician naming 
aminoglycosides.  
 
Treatment of UTIs included the same urinary analgesics and antibiotics enumerated for chistata plus 
other beta-lactam antibiotics and cephalosporins. One physician stated that gentamicin should be used 
only in very select cases, cautioning of its nephrotoxicity. When answering a question regarding the uses 
of gentamicin later in the interview, most physicians responded that it was reserved for severe UTI or 
sepsis patients. Two noted its nephrotoxicity, with one noting he sometimes had to use gentamicin due 
to the unavailability of other medications.  
 
Eight physicians acknowledged the possible nephrotoxic effects of long-term intake of NSAIDs, with six 
saying they would not prescribe them (or would restrict their use) in CKD patients. However, two 
physicians said NSAIDS are prescribed for back pain. 
 
5.3.4 Pharmacist perceptions of UTI, Chistata, CKD and their treatment  
Pharmacists did not make the distinctions that physicians did among the symptoms or conditions of low 
back pain, chistata, UTI, and CKD. Three pharmacists referred to CKD as an infection. Three said that UTI 
and chistata are the first step, or “warning,” of CKD. Three other pharmacists suggested that CKD results 
from UTIs that were either not treated or treated ineffectively.  
 
When asked specifically about prescriptions filled for CKD, eight of nine pharmacists named 
phenazopyridine (not known to be nephrotoxic) in addition to antibiotics. One pharmacist offered the 
following: “For kidney insufficiency, doctors from health centers here commonly prescribe ampoules 
called gentamicin, trimethoprim-sulfa...” This contradicts what the majority of physicians indicated as 
per gentamicin prescription. For the most part, however, pharmacists described giving the same 
medications as the physicians for treatment of chistata and UTIs plus some antispasmodic drugs and 
NSAIDs. Pharmacists did not mention oral rehydration solutions.  
 
Pharmacists’ responses revealed a range of opinions and practices regarding their role in the diagnosis 
and treatment process. On one end of the spectrum are those who would not prescribe anything until a 
patient is diagnosed by a physician, and on the other end are those willing to provide treatment directly. 
However, most said they would first recommend the patient obtain a urinalysis and have it interpreted 
by a physician. In some cases pharmacists offered to interpret lab results. Four pharmacists described 
the practice of selling antibiotics without a doctor’s prescription or a formal diagnosis. One pharmacist 
described the pressure to sell antibiotics over the counter with no diagnosis: “They’ll say, ‘Why can’t you 
give me one directly? Why do I have to go and spend money to get an exam?’ So I recommend them 
cefadroxil.” 
 
Three pharmacists said that they would first recommend diuretics: “Furosemide is the most common, I 
sell it every day.” Recognizing that diuretics could further tax the kidney, another pharmacist explained:  
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“When I sell it, I tell people to drink plenty of fluids. But at the end, that is the decision of 
people, right? But I let them know that [the medication] can damage the kidney.”  
 
Several physicians opined that pharmacists are enabling patients to self-medicate and selling potentially 
harmful medication: “The problem is that NSAIDs and gentamicin are sold in the markets of cities like 
candies” and “agricultural workers with back pain get shots of gentamicin by vendors in stores.” Taking 
diuretics for chistata was also described by two physicians:  
 
“… these patients that normally have chistata are dehydrated most of the time, so what they do 
is take a furosemide to get rid of [chistata]. And later, they arrive with cramps, more 
dehydrated, and it becomes chaos.” 
 
Table 5.2 . Further illustrative interview quotes  
CKD: A serious and growing problem in Nicaragua 
 
“In the last five years they’ve been dropping like flies, almost one person dead or very, very sick with this 
illness each day.”  (Pharmacist) 
 
“More men are affected than women… This doesn’t mean that women are not... but these are women who 
have a chronic pathology to begin with.” (Physician) 
 
“What caught my attention was that there are young people, very young, and that they are rapidly getting 
worse. We have them age 20, 23, 24, and I am telling you we have detected it in people that maybe have 
two years, and they have deteriorated, significant health deterioration…” (Physician) 
 
 “If we had family support… they are very cooperative, but they’re people of few resources, they become 
like a burden for their family, and many of them are also patients who are alone, they’re not retired, 
they’re in poverty, so really, that kind of speeds up the suffering.” (Physician) 
 
“Well, I see dehydration, with faces like [scrunched up], uncomfortable. When they have had the illness for 
a while and are deteriorating, they look yellow, thin. There are others that swell. When cases like this 
come in, I send them to the health center to get a doctor.” (Pharmacist) 
 
Causes of CKD(in Nicaragua) 
 
“Normally, they don’t present symptoms [of CKD], but the symptoms that they do present with when they 
arrive for the first time, are generally heat strokes, people are working and have cramps, nausea, 
vomiting, with fever. …After re-hydrating them, people improve and the creatinine levels after three or 
four months can lower from 2.8 or 3, to normal ranges. And they get reintegrated to work, but they still 
suffer from heat strokes. So there are possible consequences from dehydration.” (Physician) 
 
“Patients have worked in agriculture - more than anything they have been exposed to the sun a lot, they 
have been exposed to dehydration, they work with sugar cane, they work in the cotton fields.” (Physician) 
 
“The majority are young men who have worked under the sun, under the heat, and maybe they haven’t 
been drinking enough liquid when they have sunstroke or dehydration.” (Physician) 
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“Men have other factors associated with deterioration of kidney function… the use and abuse of 
substances, alcohol or drugs, strenuous exercise or work, not necessarily exposure to pesticides, but work 
in the fields, or work in areas with many hours exposed to the sun…” (Physician) 
 
“Those who are not diabetic are almost all males who work in the fields…. The most affected ones are, well, 
from the rural counties who work with pesticides and insecticides…. And then there are those from the city 
who are diabetic.” (Pharmacist) 
 
“I insist that I believe there is an interstitial nephritis, caused by something in the environment that we 
have been unable to determine.” (Physician) 
 
“Well, now we have leptospira, which means renal damage and it is also a public health problem. We had 
patients admitted here with abnormal creatinine, with confirmed diagnosis of leptospira. That is 
frequent.” (Physician) 
 
Perceptions of UTI, Chistata, CKD and their treatment 
 
“[With the general urine exam] we can have data that give us signals of a chronic kidney infection, just 
starting or advanced. CKD signs will be changes in the casts, a change in urine density; we can find a 
change in the pH, within the important phases, and the leukocyturia, that don't have an established 
etiologic cause.  That should get our attention and start us to investigate.” (Physician) 
 
“Here people say, ‘sell me something for chistata’, the majority want you to sell them furosemide pills. 
These pills dehydrate them. It’s my duty to explain to them that this pill is not for that. ‘Take the 
phenazopyridine for that.’ ‘No because that stains me (the urine), give me the half white ones please… 
look, give me the white ones, if not I’ll go shop somewhere else’.” (Pharmacist) 
 
5.4 Discussion 
Interviews of physicians and pharmacists in Western Nicaragua were consistent with the existence of an 
epidemic of CKD, describing characteristics similar to those noted in the prevalence studies conducted in 
the region (Torres, 2010; Laux, 2011; O’Donnell, 2011). These include CKD being more frequent among 
men, starting in young adulthood, and associated with mainly agricultural work but also occurring in 
miners and construction workers. The sentiment that diabetes and hypertension cannot explain the CKD 
epidemic in Nicaragua was also expressed in the interviews. If this sentiment is in based on empirical 
observations of physicians and pharmacists, these findings provide additional verification of the findings 
of local studies.  
 
The primary contribution of this study, however, is highlighting medication usage patterns described by 
physicians and pharmacists that have not previously been well characterized in cohort studies and 
government data, and which may lead to increased risk of CKD among younger men in this region. 
 
Interviews indicate that patients with CKD, or at high risk for CKD, may be receiving nephrotoxic drugs 
for the syndromes of chistata and UTI. In particular, aminoglycoside antibiotics and chronic use of 
NSAIDs are associated with acute kidney injury (AKI) in a dose- and duration-dependent manner 
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(Harirforoosh et al, 2009; Sweileh, 2009; Lopez-Novoa et al, 2011). This association is particularly 
notable in the setting of volume depletion, which may be further aggravated due to the use of diuretics. 
Reports that attempt to quantify regional NSAIDs use vary widely, with self-reported use ranging from 
10 to 75% of study populations (Torres et al, 2010; O’Donnell et al, 2011; Orantes et al, 2011). 
 
Despite the media attention given to the potential role of agrichemicals in causing CKD, physicians and 
pharmacists were much more likely to cite exposure to heat, physical work and dehydration as key 
factors responsible for CKD; a common combination of exposures among men in this region and in 
Central America (Delgado-Cortez, 2009; Crowe et al, 2009; Kjellstrom et al, 2011; McClean et al, 2011). 
This opinion is consistent with local and regional studies, which find that CKD appears more common 
among occupations where strenuous work undertaken at high ambient temperatures is typical (Torres 
et al, 2010; Sanoff et al, 2010, O’Donnell et al, 2011; Laux, 2011; Peraza, 2012; Weiner et al, 2012; 
Brooks et al, 2012). Although not a recognized cause of CKD, heat stress is associated with volume 
depletion and may also be associated with muscle damage (rhabdomyolysis), both of which may 
predispose individuals to AKI, particularly in the presence of nephrotoxic medications (Schrier et al, 
1967; Demos et al, 1974). Critically, there is a growing body of literature that suggests that AKI, even if 
mild or if the serum creatinine recovers to baseline, may result in residual structural damage and 
ultimately progress to clinically recognized CKD  (Coca et al, 2007; Levin et al, 2008; Venkatachalam et al, 
2010; Coca et al, 2012; Bedford et al, 2012).   
 
Figure 5.1 demonstrates the relationships, with different degrees of certainty, identified by interviewees 
regarding several key causal hypotheses, beginning with the relationship between occupational 
exposure to heat and manual labor, followed by the occurrence of Chistata and diagnosis of UTI, use of 
medications, and eventual CKD, while including other potentially nephrotoxic exposures in what is 
largely considered to be a multi-factorial disease.  
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Figure 5.1– Conceptual Model of Excess Heat Hypothesis 
 
 
 
Our interviews provide inconsistent yet important information regarding the perceived role of drinking 
water in CKD, with half the pharmacists believing that not drinking enough water leads to CKD, and the 
other half believing that CKD may be caused by drinking contaminated water. These beliefs, taken at 
surface value, would result in contradictory recommendations to area residents and workers. However, 
it is too early to say which view is correct and the truth may lie somewhere in between. Even if drinking 
water contaminants are not known to directly cause CKD, it cannot be concluded that drinking water 
quality is acceptable in various areas. Additionally, the emphasis of interviewees was that dehydration is 
due in part to perceptions of water and water consumption practices. The question remains, is 
hydration in general recommended or water consumption specifically? If lacking clean water, should 
workers and the general public be advised to hydrate with soda or fruit juices? What are the risks and 
benefits of hydrating with these high-sugar fluids compared with unclean water? To the extent that the 
contradictory views of pharmacists may represent those in the broader community, further examination 
of these questions would be beneficial before public health professionals design interventions with 
messages simply exhorting people to drink more water. 
 
According to both physicians and pharmacists, UTI is one of the main causes of chistata. However, in 
medical practice elsewhere UTI is very uncommon among younger men with the rare cases typically 
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associated with congenital urinary tract abnormalities or obstruction such as from nephrolithiasis. Urine 
cultures analyzed by our group from 47 male workers whose urine dipstick results were positive for 
leukocyte esterase or who had complained of dysuria within the past 24 hours were all negative for 
bacterial growth (McClean et al, 2012), supporting the impression of some physicians that UTI is likely 
over-diagnosed.  
 
Exposures to agrichemicals, heavy metals, alcohol consumption and infectious agents were also 
mentioned in physician and pharmacist interviews and are the focus of additional causal hypotheses in 
the region (Torres et al, 2010; O’Donnell et al, 2011; Sanoff et al, 2011; Orantes et al, 2011). In 
particular, infection by leptospirosis, although mentioned by only one interviewee, is considered an 
occupational hazard for people who work outdoors, including sugar-cane field workers, and a high 
seroprevalence of leptospirosis has been described in northwestern Nicaragua (Ashford et al, 2000; 
WHO, 2003). Manifestations of leptospirosis range from subclinical infection to severe disease 
accompanied by acute kidney failure. To date, there has been little research regarding the potential for 
leptospirosis infection to cause chronic tubular dysfunction or CKD in the absence of severe acute illness 
(Daher et al, 2004; Cerqueira et al, 2008; Ganoza et al, 2010).  
 
Limitations of our study include the inability to determine the truthfulness and accuracy of interviewee 
responses, and the small number of physicians and pharmacists interviewed. Qualitative studies are 
rarely designed to have statistically representative samples of the population, but for several of our 
questions we could have learned more about the general practice among physicians in particular if we 
had been able to conduct more interviews and achieved a higher degree of redundancy in the 
responses. However, these interviews have highlighted several potential contributors to CKD in 
Nicaragua including heat stress and use of potential nephrotoxic medications, supporting the plausibility 
of a multi-factorial cause of CKD. These findings also provide impetus for future cohort studies designed 
to examine such exposures and diagnoses. 
 
Recommendations 
Many features of CKD in Central America require further elucidation. These include identifying the true 
cause of “chistata” and UTI-like symptoms, evaluating potential associations among heat stress, UTI 
diagnosis and nephrotoxic medication use, evaluating the role of systemic infectious diseases, and 
assessing the potential contribution of all of these factors to the development of CKD. However, until 
such time, the possible association between the occupational exposure to heat and the use of 
potentially nephrotoxic medications may be a beneficial focus of regional preventive health programs 
(Ramirez-Rubio, 2013a), including at the workplace, at the community level, and in health care settings. 
Surveillance systems of worker symptoms of heat exposure and workload, together with hydration 
practices, could be consolidated by governmental agencies, periodically assessed for lessons 
learned/best practices, and shared with employers. Similarly, there have been several assessments of 
water quality in specific areas. These assessments could be compiled with a similar analysis, identifying 
and addressing data gaps with further testing, so (a) public health professionals can make scientifically-
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based recommendations regarding consumption of water, and (b) local health agencies could come up 
with rapid and inexpensive processes to check for local variability (e.g., arsenic may be an issue in some 
areas, not in others). Overall, research into current hydration practices and promoters, and obstacles to 
greater hydration, could help shape public health recommendations. 
 
Common self-medication reported by pharmacists and physicians of widespread (across the community 
and particularly workers) dysuria related symptoms with diuretics, NSAIDs and antibiotics could be the 
target of greater oversight and health protection measures from government agencies. The 
contradiction between pharmacists reporting that physicians prescribe gentamicin, and physicians 
reporting otherwise, could also be explored via observations at pharmacies where prescriptions are 
filled. Finally, we recommend increased and targeted education for pharmacists and physicians on the 
diagnosis and treatment of heat exposure symptoms, UTIs and CKD, along with strategies that may 
assist pharmacists when confronted with patients who demand medications that may be nephrotoxic. 
 
Conclusions 
High mortality has been documented due to CKD among young adult men in Northwest Nicaragua, and 
specific areas of Central America including regions of El Salvador and Costa Rica, the cause of which 
remains unknown. This study identifies perceived causes of the CKD epidemic in Nicaragua by physicians 
and pharmacists working on the front line. Our analysis articulates perceptions of physicians and 
pharmacists that heat stress and subsequent volume depletion experienced by manual laborers plays a 
role in the frequent occurrence of dysuria-like symptoms, which are often treated with non-steroidal 
anti-inflammatory drugs, diuretics and antibiotics that may be further nephrotoxic. 
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CHAPTER VI: KIDNEY DAMAGE AMONG 
NICARAGUAN ADOLESCENTS  
“All grown-ups were once children... but only few of them remember it.” 
― Antoine de Saint-Exupéry, The Little Prince   
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6.1 Introduction 
 
An epidemic of chronic kidney disease of unknown cause/s (CKDu), also called Mesoamerican 
Nephropathy (MeN), is occurring across that region (Weiner et al, 2013; Ramirez-Rubio et al, 2013a, 
Wesseling et al, 2013). CKD constitutes the second leading cause of death among adult males in El 
Salvador (El Salvador MoH, 2010), and the prevalence of the disease is 20% or greater in some 
communities, following a cluster pattern (Torres et al, 2010; Peraza et al, 2010).  In addition to the toll 
on the health of the population, the epidemic has had a substantial negative impact on the social and 
economic well-being of the affected communities.  
Community prevalence studies indicate that relatively young men who engage in strenuous outdoor 
work (e.g. agriculture, mining, etc), and live in the lowlands of the Pacific coast are among the most 
affected (Garcia-Trabanino et al, 2005; Torres et al, 2010; O’Donnell et al, 2010; Sanoff et al, 2010; 
Orantes et al, 2011; Laux et al, 2011; Peraza et al, 2012). These studies have also helped to characterize 
CKDu/MeN, mainly, as a tubulo-interstitial non-proteinuric nephropathy, where diabetes and 
hypertension do not explain the vast majority of the cases.   
The etiology is presumably multifactorial (Wesseling et al, 2013; Ramirez-Rubio et al, 2013a), and there 
are a variety of hypothesized causes: heat and heavy physical work load (chronic volume depletion), 
heavy metals such as arsenic or cadmium, agrichemicals, systemic infectious diseases such as 
leptospirosis, and chronic intake of potential nephrotoxic medications such as non-steroidal anti-
inflammatory drugs (NSAIDs), analgesics or aminoglycoside antibiotics (Soderland 2010) that are used 
for a wide range of symptoms (Ramirez-Rubio et al, 2013b). It has been hypothesized (Brooks et al, 
2012, Wesseling et al, 2013) that chronic volume depletion coupled with muscular damage, although 
not a recognized cause of CKD, might result in repeated bouts of clinical or subclinical acute kidney 
damage (AKI), that eventually could lead to CKD (Bedford et al, 2012).  
Studies to date have focused on the general adult population or on workers in occupational settings. 
However, because many of the affected adults are diagnosed with CKD at very young ages, and because 
most of the hypothesized etiologic factors could already be present (perhaps with less intensity) earlier 
in life, we hypothesized that initial damage to the kidney may begin in childhood. Markers of tubular 
damage may appear before there is a sufficient reduction in glomerular filtration to result in an 
elevation of serum creatinine, the most conventional biomarker of CKD. The aim of this exploratory 
study was to investigate novel biomarkers of early kidney damage among Nicaraguan adolescents who 
have not yet entered the workforce, in order to further explore factors associated with the initiation and 
progression of CKD in this context. 
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6.2 Methods 
6.2.1 Study design  
We conducted a cross-sectional study among adolescents aged 12-18 in four different schools in 
Nicaragua. Schools were selected to represent a range of demographic, geographic, and environmental 
factors that have been associated with CKD mortality among adults. Among others, altitude of the 
community (i.e. lower altitude has been associated with a higher prevalence of CKD in adults), and 
occupation (i.e. workers at the sugar cane industry have showed higher CKD prevalence). Based on these 
factors, schools were ranked in an increasing order of a priori risk of CKD. School 1 was located in the 
department of Jinotega (adult CKD mortality rate of 5 per 100,000 inhabitants in 2010) at an altitude of 
800 meters above sea level and surrounded by coffee plantations. School 2 was located in the 
department of Masaya (2010 CKD mortality rate = 12 per 100,000) at 220 meters above sea level near 
the Pacific in an area dedicated mainly to small farms and predominantly artisan-related occupations. 
School 3 and 4 were both based in the same city in the department of Chinandega (2010 CKD mortality 
rate = 95 per 100,000), an area in the Pacific region located almost at sea level, and characterized by 
production of crops such as sugar cane, rice, and peanuts. School 4 participants were restricted to 
students whose parents (one or both) had worked in the sugar cane industry. At the remaining schools, 
we excluded children if either parent had ever worked in the sugar cane industry.  
The study protocol was approved by the Institutional Review Boards at the Boston University Medical 
Center and the Nicaraguan Ministry of Health. As the study population was mainly younger than 18 
years old, the parents of all study subjects provided written informed consent and adolescents were 
asked to provide assent prior to participation in the research activities. 
 
6.2.2 Study population 
To be eligible, students must have never worked in a manual labor job (defined as at least one month of 
manual labor, whether paid or not). Students who had previously participated in sports or vigorous 
exercise on the same day as samples were being collected, and female students who were currently 
menstruating, were also excluded.  
 The recruitment process was planned in coordination with the Ministry of Education’s (MOE) officials, 
including the heads of the MOE at the Department and municipal levels, and the schools’ teachers. Our 
goal was to recruit at least 50 students at each school, with an equal distribution of male and female, 
and older (16-18 years) and younger (12-15 years) students. A flow chart of the study population at 
different stages is shown in Figure 2. Information regarding the purpose, procedures, and inclusion and 
exclusion criteria was briefly described to students in their classrooms. A packet of material containing a 
letter of invitation to the study, a parental consent and permission form, and a brief questionnaire was 
sent home with interested students.  
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After review of the invitation letter, interested parents returned the signed consent form the following 
day, together with a parental questionnaire, which solicited information on eligibility criteria and 
general family characteristics, including parents’ vital status, education, length of residence in the area, 
current and longest occupation, whether either parent had ever held a job in the sugar cane industry, 
parents’ medical history (CKD, kidney stones, hypertension and diabetes), and brief questions about the 
child’s kidney health and medical history.  
We included all students who met eligibility criteria based on the parental questionnaire. Study staff 
then asked the children to assent to participate. Those children who signed the assent form were then 
asked to complete a questionnaire (student’s demographics, past work history, prior participation in 
sports or vigorous exercise on that day, length of time walked to school in the morning, current health 
problems, and frequency of urinary symptoms), which was reviewed to assess final eligibility (current 
menstruation status was obtained verbally by a female study staff member).   
 
6.2.3 Sample collection 
Urine samples were collected by the field study personnel in the morning before classes started to 
increase the likelihood that all samples would be taken before students became physically active.  Prior 
to providing urine samples, participants were asked to wash their hands with soap and clean the 
perineal/genital area with an alcohol pad. Each adolescent was asked to void into a sterile, 100-mL red-
topped container (Nipro). Urine samples collected at Schools 1 and 2 were immediately placed in a 
cooler and transported on the day of the collection to the National Laboratory Center for Diagnostic and 
References (CNDR) in Managua for storage at -80 °C.  Samples in schools 3 and 4 were transported to 
the local Health Center, where they were aliquoted and stored at -20 °C (for a period of days to a week 
maximum) until transported to the CNDR.  
 
6.2.4 Sample analysis 
Urine dipstick analyses were conducted on all 245 students to semi-quantitatively assess specific gravity, 
pH, leukocyte esterase, nitrite, protein, glucose, ketones, urobilinogen, bilirubin, and blood. A urine 
dipstick (Combur 10UX®, Roche Diagnostics) and a urine strip reader (Urisys 1100, Roche Diagnostics) 
were used.  
Biomarkers of kidney damage were measured in urine samples collected from 200 participants (i.e. 50 
participants randomly selected at each of the four schools equally distributed by sex and age category) 
(see Figure 2). Urine samples were shipped to the Division of Nephrology and Hypertension at the 
Cincinnati Children's Hospital Medical Center (Cincinnati, OH, USA), and were analyzed for albumin 
(µg/mg creatinine), a standard marker of increased glomerular permeability and damage, (NKF, 2002); 
neutrophil gelatinase-associated lipocalin (NGAL) (mU/mg creatinine),  a marker increased when kidney 
tubules are acutely damaged (Hasse, 2009; Devarajan, 2008); N-acetyl--D-glucosaminidase (NAG) 
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(ng/mg creatinine), a marker of proximal tubular epithelial cells damage (Skalova, 2005); and 
interleukin-18 (IL18) (pg/mg creatinine), a cytokine indicative of tubule inflammation and necrosis 
(Parikh, 2005). Urine creatinine (mg/ml) was also determined in order to normalize the urinary 
biomarkers according to urine concentration. Albumin and creatinine were measured by 
immunoturbidimetry and a colorimetric modification of the Jaffe reaction, respectively, on a Siemens 
Dimension Xpand plus HM chemistry analyzer (Siemens Healthcare Diagnostics, Deerfield, IL). NAG 
activity was measured using a colorimetric assay (Roche Diagnostics, USA). NGAL (Bioporto, Gentofte, 
Denmark) and IL18 (MBL, Intl., Woburn, MA) were measured by enzyme-linked immunosorbent assay 
(ELISA). The time between urine collection and analysis of biomarkers ranged from 30-45 days. 
Figure 6.1- Adolescent study population flow chart 
 
307 study 
participants
273 eligible with 
questionnaire data
200 with urine early 
kidney damage 
markers
34 non 
eligible
Reasons:
-13 menstruating
-15 working adolescents
-6 sugar cane working 
parents
245 with dipstick 
data
28 not present at sample 
site collection
Selection of 50 adolescents per school 
(25 males and 25 females, age categories 
equally represented)
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6.2.5 Data analysis 
Information from questionnaires, urine dipsticks, and kidney biomarkers was merged and analyzed using 
SPSS statistical software (version 18). The distribution of each biomarker was characterized using 
graphical displays and summary statistics. When the reported value was less than the limit of detection 
(LOD), the LOD divided by the square root of 2 was substituted. The exception was for NAG since no LOD 
was available; we substituted them using a value equal to the lowest reported value divided by the 
square root of two. All biomarkers exhibited a lognormal distribution and were natural log-transformed 
prior to analysis to satisfy normality assumptions. 
Linear regression models were used to assess potential predictors of biomarkers of kidney damage. 
Because the biomarker concentrations were natural log-transformed for the purpose of analysis, the 
exponentiated β estimates (eβ) can be interpreted as multiplicative differences or “mean ratios” for 
each index variable category compared to the mean of the reference variable category.  We used 
directed acyclic graphs (DAG) to identify potential confounders (Hernan, 2006). One of the main 
objectives was to evaluate differences in urinary biomarkers by school (four categories), which served as 
a proxy for the region of residence and for differential environmental exposures and/or parents’ 
occupations. Fathers’ education (as a proxy for socio-economic status), and length of residence (as a 
proxy for accumulation of community environmental or parents’ occupational exposures) were entered 
in the models to adjust for confounding based on their effect on the estimate of association (>10% 
change) between school and the kidney damage biomarkers. Although sex and age were not 
confounders because they were balanced across schools as part of the study design, which we 
confirmed empirically, we included both as covariates in all multivariate adjusted models because it 
increased the precision of the estimates for some biomarkers. We also conducted linear regression 
analyses of the association between kidney injury biomarkers and selected parameters measured by 
urine dipstick.  
6.3 Results 
 
6.3.1 Population characteristics 
 
A total of 245 students (51% females) were enrolled and provided questionnaire information. Table 6.1 
summarizes the demographics of the study population and relevant information on the adolescents and 
their parents’ health. 
 
The sex distribution among students was quite similar across schools, while the proportion of younger 
students was slightly higher at School 1 and 4. We also assessed the type of transport and time walked 
to get to the school. Among those who walked, the median time to get to school was 10 minutes, with a 
minimum of 1 and a maximum of 60 minutes. Only 5% of children at Schools 1 and 4 walked ≥30 
minutes compared to 13%-18% at Schools 2 and 3. Regarding self-reported urinary symptoms and 
“kidney” disease, a total of 23 parents reported their child (12 boys and 11 girls) to suffer from kidney 
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problems, with no significant differences by school (p=0.967). ¨Kidney” related reasons for 
hospitalization reported by parents included:  “kidney infections” (17), “urinary problems” (2), urinary 
tract infections (1), “kidney problems” (1), “kidney stones” (1), and “kidney insufficiency” (1). A total of 
15 children (10 girls and 5 boys) reported kidney problems, with no significant differences by school 
(p=0.269). In particular they used terms such as: “kidney infection” (5), “kidney problems” (4), “Pain or 
burning while urinating” (4), and “kidney pain” (2). The proportion of students who reported “suffering 
from pain while urinating” frequently (1-2 times per month or weekly), were 10% in School 1, 23% in 
School 2, 24% in School 3, and 15% in School 4. Urine biomarkers of kidney injury were not associated 
with self-reported frequent dysuria, nor with kidney or urinary problems reported by either parents or 
children (results not shown). 
 
Parents had resided in the same region within Nicaragua for a median of 33 years (range 2-57), with no 
significant differences among schools. Almost no parents of students at School 4 had completed a 
university or professional education compared to a range of 17%-30% at the other schools. Schools 2 
and 4 showed the highest percentage of fathers (51 and 54% respectively) who did not have education 
beyond primary school, compared to about a third of those at the other schools. Among mothers, the 
percentage with no more than a primary school education was much higher at School 4 (62%) than 
among the other schools (28%-42%). At School 4 (where almost all parents were sugar cane workers as 
per the study design), 13% of students’ fathers had died compared to 5%-6% at the other schools. The 
same pattern was observed for self-reported CKD, with relatively low rates (2-6%) among mothers 
across all schools, while 36% of fathers at School 4 reported CKD compared to 2%-6% at the other 
schools.  
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Table 6.1 Characteristics of the study population 
 
Schools 1. Jinotega  2. Masaya 3. Chinandega 4. Chinandega TOTAL 
 n=63 n=52 n=63 n=67 N=245 
  n (%) n (%) n (%) n (%) n (%) 
ADOLESCENTS’ CHARACTERISTICS 
Sex      
 
Male  33 (52%)  25 (48%)  32 (51%)  31 (46%)  121 (49%) 
    Female  30 (48%)  27 (52%)  31 (49%)  36 (54%)  124 (51%) 
Age group       
12-15y  37 (59%)  25 (48%)  33 (52%)  38 (57%)  133 (54%) 
16-18y  26 (41%)  27 (52%)  30 (48%)  29 (43%)  112 (46%) 
Minutes walked to school      
<10 15 (26%) 7 (16%) 8 (15%) 37 (62%) 67 (31%) 
10-29 39 (69%) 30 (67%) 38 (72%) 20 (33%) 127 (59%) 
≥30 3 (5%) 8 (18%) 7 (13%) 3 (5%) 21 (10%) 
Symptoms      
Pain while urinating      
Never 38 (60%) 21 (40%) 30 (48%) 44 (66%) 133 (54%) 
1-2/year 19 (30%) 19 (37%) 17 (27%) 13 (19%) 68 (28%) 
1-2/month 5 (8%) 8 (15%) 11 (18%) 5 (7.5%) 29 (12%) 
1/week 1 (2%) 4 (8%) 4 (7%) 5 (7.5%) 14 (6%) 
"Kidney" problems  7 (11%) 8 (15%) 9 (14%) 8 (12%) 32 13%) 
Reported by child 4 (6%) 6 (12%) 2 (3%) 3 (4%) 15 (6%) 
Reported by parent 6 (10%) 5 (10%) 7 (11%) 5 (7%) 23 (9%) 
PARENTS’ CHARACTERISTICS 
Years parents lived in the same region (department) 
<5 0 (0%) 1 (2%) 0 (0%) 0 (0%) 1 (0.4%) 
5-9 0 (0%) 0 (0%) 2 (3%) 0 (0%) 2 (0.8%) 
10-19 10 (16%) 13 (27%) 19 (31%) 17 (26%) 59 (24.7%) 
20+ 53 (84%) 35 (71%) 40 (66%) 49 (74%) 177 (74.1%) 
Father education      
No school 1 (1.5%) 2 (5%) 4 (7%) 6 (10%) 13 (6%) 
Primary 15 (24.5%) 19 (46%) 15 (27%) 28 (44%) 77 (34.5%) 
Secondary 31 (51%) 14 (33%) 23 (41%) 27 (43%) 95 (43%) 
University/professional  14 (23%) 7 (17%) 14 (25%) 2 (3%) 37 (16.5%) 
Mother education      
No school 0 (0%) 1 (2%) 0 (0%) 3 (5%) 4 (2%) 
Primary 17(28%) 17 (40%) 20 (34%) 34 (57%) 88 (39%) 
Secondary 26 (43%) 16 (37%) 28 (47%) 23 (38%) 93 (42%) 
University/professional  18 (29%) 9 (21%) 11 (19%) 0 (0%) 38 (17%) 
Sugar cane parent job      
Father or mother worked in 
sugar cane 0 (0%) 0 (0%) 1 (2%) 63 (94%) 64 (26%) 
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Parents' health reported background     
Either parent reported CKD 7 (11%) 3 (6%) 4 (6%) 26 (39%) 40 (16%) 
Father      
CKD 4 (6%) 1 (2%) 4 (6%) 24 (36%) 33 (16%) 
Kidney stones 7 (11%) 1 (2%) 1 (2%) 6 (9%) 15 (7%) 
Hypertension 8 (13%) 6 (12%) 6 (10%) 12 (18%) 32 (13%) 
Diabetes 7 (11%) 3 (6%) 5 (8%) 3 (5%) 18 (9%) 
Deceased 3 (5%) 3 (6%) 3 (5%) 9 (13%) 18 (8%) 
Mother      
CKD 4 (6%) 2 (4%) 1 (2%) 3 (5%) 10 (5%) 
Kidney stones 6 (10%) 4 (8%) 1 (2%) 3 (5%) 14 (7%) 
Hypertension 11 (18%) 11 (21%) 8 (13%) 12 (18%) 42 (20%) 
Diabetes 2 (3%) 2 (4%) 4 (6%) 4 (6%) 12 (6%) 
Deceased 0 (0%) 0 (0%) 3 (5%) 2 (3%) 5 (2%) 
 
 
6.3.2 Dipstick 
Dipstick data were available on all 245 study participants (Table 6.2). A higher proportion of girls than 
boys had values of urine specific gravity in the three highest hexiles of urine specific gravity (34.7% vs. 
22.3%, respectively; p=0.0005), indicating that girls had more concentrated urine. Both leukocyte 
esterase and nitrites were only very rarely detected in the study population. Nitrites were detected only 
in 5 adolescents (2%). 23 (9.4%) adolescents had a positive leukocyte esterase, of whom 22 were 
females evenly distributed among schools.  Protein (7 cases or 2.9%) or glucose (2 cases or 0.8%) was 
only rarely present in the urine of study participants. 
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Table 6.2- Urine dipstick measures by school and sex (n=245) 
 SCHOOL  (Department)   SEX  TOTAL 
 
1. Jinotega  2. Masaya 3. Chinandega 4. Chinandega  Females Males  Total 
  n=63 n=52 n=63 n=67  n=124 n=121  N=245 
Urine dipstick 
measures 
n (%) n (%) n (%) n (%)  n (%) n (%)  n (%) 
SPECIFIC GRAVITY          
1,005 4 (6%) 2 (4%) 7 (11%) 16 (24%)  13 (10%) 16 (13%)  29 (12%) 
1,010 14 (22%) 19 (37%) 18 (29%) 25 (37%)  30 (24%) 46 (38%)  76 (31%) 
1,015 18 (29%) 12 (23%) 20 (32%) 20 (30%)  38 (31%) 32 (27%)  70 (29%) 
1,020 19 (30%) 12 (23%) 14 (22%) 6 (9%)  29 (23%) 22 (18%)  51 (21%) 
1,025 4 (6%) 3 (6%) 3 (5%) 0 (0%)  6 (5%) 4 (3%)  10 (4%) 
1,030 4 (6%) 4 (8%) 1 (2%) 0 (0%)  8 (7%) 1 (1%)  9 (3%) 
pH          
5 41 (65%) 25 (48%) 26 (41%) 19 (28%)  66 (53%) 45 (37%)  111 (45%) 
6 10 (16%) 11 (21%) 19 (30%) 24 (36%)  27 (22%) 37 (31%)  64 (26%) 
6.5 1 (2%) 3 (6%) 3 (5%) 7 (10%)  4 (3%) 10 (8%)  14 (6%) 
7 8 (13%) 9 (17%) 10 (16%) 12 (18%)  18 (15%) 21 (17%)  39 (16%) 
8 3 (5%) 4 (8%) 5 (8%) 5 (8%)  9 (7%)  8 (7%)  17 (7%) 
LEUKOCYTE ESTERASE          
Neg 57 (90%) 46 (88%) 58 (92%) 61 (91%)  102 (82%) 120 (99%)  222 (91%) 
+1 3 (5%) 2 (4%) 0 (0%) 1 (1.5%)  6 (5%) 0 (0%)  6 (2%) 
+2 1 (2%) 4 (8%) 2 (3%) 1 (1.5%)  7 (6%) 1 (1%)  8 (3%) 
+3 2 (3%) 0 (0%) 3 (5%) 4 (6%)  9 (7%) 0 (0%)  9 (4%) 
NITRITE          
Neg 63 (100%) 51 (98%) 61 (97%) 65 (97%)  122 (98%) 118 (97%)  240 (98%) 
Pos 0 (0%) 1 (2%) 2 (3%) 2 (3%)  2 (2%) 3 (3%)  5 (2%) 
BLOOD          
Neg 55 (87%) 45 (86%) 57 (90%) 60 (90%)  102 (82%) 115 (95%)  217 (89%) 
+1 2 (3%) 4 (8%) 1 (2%) 3 (4%)  9 (8%) 1 (1%)  10 (4%) 
+2 1 (2%) 3 (6%) 2 (3%) 2 (3%)  5 (4%) 3  (2%)  8 (3%) 
+3 2 (3%) 0 (0%) 2 (3%) 0 (0%)  4 (3%) 0 (0%)  4 (2%) 
+4 3 (5%) 0 (0%) 1 (2%) 2 (3%)  4 (3%) 2 (2%)  6 (2%) 
PROTEIN          
Neg 63 (100%) 48 (92%) 61 (97%) 66 (99%)  122 (98%) 116 (96%)  238 (97%) 
+1 0 (0%) 3 (6%) 2 (3%) 0 (0%)  1 (1%) 4 (3%)  5 (2%) 
+2 0 (0%) 0 (0%) 0 (0%) 0 (0%)  0 (0%) 0 (0%)  0 (0%) 
+3 0 (0%) 1 (2%) 0 (0%) 1 (1%)  1 (1%) 1 (1%)  2 (1%) 
GLUCOSE          
Neg 63 (100%) 50 (96%) 63 (100%) 67 (100%)  123 (99%) 120 (99%)  243 (99%) 
+1 0 (0%) 1 (2%) 0 (0%) 0 (0%)  0 (0%) 1 (1%)  1 (0.5%) 
+2 0 (0%) 1 (2%) 0 (0%) 0 (0%)  1 (1%) 0 (0%)  1 (0.5%) 
KETONES          
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Neg 63 (100%) 52 (100%) 62 (98%) 67 (100%)  124 (100%) 120 (99%)  244 (99.5%) 
+1 0 (0%) 0 (0%) 1 (2%) 0 (0%)  0 (0%) 1 (1%)  1 (0.5%) 
UROBILINOGEN          
Neg 63 (100%) 52 (100%) 60 (95%) 67 (100%)  124 (100%) 118 (98%)  242 (99%) 
+1 0 (0%) 0 (0%) 2 (5%) 0 (0%)  0 (0%) 3 (2%)  3 (1%) 
BILIRUBIN          
Neg 63 (100%) 52 (100%) 63 (100%) 67 (100%)  124 (100%) 121 (100%)  245 (100%) 
 
6.3.3 Urinary biomarkers 
 
200 adolescents (50 per school) had their albumin, IL-18, NGAL, and NAG in urine evaluated. All analyses 
were adjusted for urinary creatinine to adjust for urine concentration. The median urinary creatinine 
concentration value in male adolescents was lower as compared to female adolescents, 72 mg/dl (IQR 
45-122) vs. 105 mg/dl (IQR 47-155) respectively (P<0.01), which was consistent with the differences 
between males and females in urine specific gravity by dipstick. 
Sixteen students (8%) had an albumin in the range of microalbuminuria (≥30 ug/mg of creatinine), 
including only one higher than 300 ug/mg (a boy from School 4).  
 
Linear regression models evaluated the association between the biomarkers concentration and sex, age, 
and school, adjusted for confounding (table 6.3). Boys had similar albumin creatinine ratio (ACR) mean 
concentrations compared to girls (0.86, 95%CI: 0.64-1.15). Among girls, the relative mean ACR 
concentration was lowest at School 2 and School 3. 
 
Mean concentrations of NGAL in boys were one quarter of those in girls (0.25, 95%CI: 0.20-0.32). As age 
increased the mean concentration of NGAL increases by 9% per year (1.09, 95%CI: 1.02-1.16). The mean 
values of NGAL were at least 40% higher in School 4 than in School 1, both in males (1.56, 95%CI: 1.01-
2.40) and females (1.42, 95%CI: 0.84-2.41).  
Mean concentrations of NAG for boys were 21% lower than for girls (0.79, 95%CI: 0.59-1.04), and 
decreased 8% for each year of age (0.92, 95%CI: 0.85-0.99). The mean ratio concentrations of NAG were 
elevated among students at all schools (compared to School 1), particularly at the two schools in the 
department of Chinandega.  School 3 had a mean concentration 1.97 times higher (95%CI: 1.34-2.88) 
and School 4 2.77 times higher (95%CI: 1.85-4.16) than School 1. Similar results were found when 
females and males were analyzed separately.  
 
Mean concentrations of IL-18 were 72%  lower in boys than in girls (0.28, 95%CI: 0.22-0.36), and there 
was no association with age. Mean concentrations of IL-18 were lower in all schools compared to School 
1.  However, when analyzed independently, females showed a decreased mean ratio values in all three 
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schools, while males in School 4 showed an increased mean ratio values when compared to School 1 
(1.52, 95%CI: 0.93-2.50). 
 
We also examined whether individuals with higher values of one biomarker were more likely to also 
have higher values of the other biomarkers as well. Taking the 75th percentile as a cutoff point for each 
of the biomarkers, 33% of the population had one biomarker above P75, 20% had two, 7% three, and 1% 
all four biomarkers. The percentage of students with at least at two biomarkers above P75 differed by 
school: 32% at School 1, 8% at School 2, 28% at School 3, and 44% at School 4 (p=0.001). Non-
parametric correlations between the four biomarkers yielded mostly significant but weak correlation 
coefficients from 0.1 to 0.54.  
 
We further analyzed whether leukocyte esterase positivity in females was associated with biomarkers of 
kidney injury. The mean of NGAL values was 2.13 (95% CI 1.46-3.12) times higher in leukocyte esterase 
positive females compared to leukocyte esterase negative females, but there were no differences for 
any of the other biomarkers. 28 (11.4%) adolescents tested positive for hemoglobin, with 22 being 
females evenly distributed among schools. IL-18 showed a higher relative mean (1.64, 95% CI 1.10-2.44) 
when we analyzed whether hematuria was associated with higher values of biomarkers of kidney injury 
in females. Lastly, urine biomarkers of kidney injury were not associated with any kidney or urinary 
problems reported by either parents or children. 
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 Table 6.3- Urine biomarker’s median and relative mean concentrations, by sex, age, and school (n=200) 
  
Abbreviations: IQR, interquartile range; CI, confidence interval 
* Crude relative means 
Adjusted relative means: 
a. Adjusted for age, parents’ length of residence in the same address, father's education      
b. Adjusted for sex, parents’ length of residence in the same address, father's education      
c. Adjusted for sex, age, parents’ length of residence in the same address, father's education   
N Median (IQR) Relative mean* Relative mean Median (IQR) Relative mean* Relative mean Median (IQR) Relative mean* Relative mean Median (IQR) Relative mean* Relative mean
pg/mg Creatinine (95% CI) (95% CI) ng/mg Creatinine (95% CI) (95% CI) mU/mg 
Creatinine
(95% CI) (95% CI) ug/mg 
Creatinine
(95% CI) (95% CI)
Overall 200 56.7 (28.9-122.8) N/A N/A 13.3 (6.3-28.1) N/A N/A 1.5 (1.0-2.2) N/A N/A 6.2 (4.6-10.5) N/A N/A
Sex
  F 100 117.7 (66.5-178.8) Ref Ref 25.7 (15.6-49.6) Ref Ref 1.6 (1.2-2.2) Ref Ref 7.5 (5.4-11.5) Ref Ref
  M 100 32.3 (21.3-53.1) 0.28 (0.22-0.35) 0.28 (0.22-0.36)a 7.0 (4.2-10.9) 0.26 (0.21-0.32) 0.25 (0.20-0.32)a 1.4 (1.0-2.1) 0.79 (0.59-1.06) 0.79 (0.59-1.04)a 5.2 (4.1-7.7) 0.80 (0.61-1.04) 0.86 (0.64-1.15)a
Age
1 y incre. 200 N/A 0.97 (0.89-1.06) 0.97 (0.90-1.04)b N/A 1.10 (1.01-1.19) 1.09 (1.02-1.16)b N/A 0.90 (0.83-0.98) 0.92 (0.85-0.99)b N/A 0.96 (0.89-1.04) 0.96 (0.88-1.04)b
School
  1 Jinotega 50 54.1 (34.5-165.4) Ref Ref 12.0 (6.8-26.1) Ref Ref 1.3 (0.5-2-2) Ref Ref 5.3 (4.0-17.4) Ref Ref
  2 Masaya 50 41.9 (20.4-119.3) 0.63 (0.42-0.96) 0.66 (0.46-0.95)c 13.1 (6.2-21.9) 0.88 (0.58-1.32) 0.95 (0.68-1.33)c 1.3 (0.9-1.6) 1.20 (0.82-1.76) 1.26 (0.84-1.88)c 7.1 (5.1-8.8) 0.95 (0.65-1.39) 0.96 (0.63-1.47)c
  3 Chinandega 50 48.2 (25.4-115.3) 0.76 (0.51-1.15) 0.76 (0.54-1.08)c 11.4 (5.2-38.7) 0.98 (0.65-1.47) 0.96 (0.70-1.32)c 1.6 (1.3-2.1) 2.01 (1.37-2.94) 1.97 (1.34-2.88)c 6.1 (4.6-10.3) 0.89 (0.61-1.30) 0.89 (0.59-1.33)c
  4 Chinandega 50 78.8 (38.3-121.1) 1.01 (0.67-1.53) 0.93 (0.65-1.34)c 15.1 (8.2-34.2) 1.23 (0.82-1.85) 1.42 (1.02-1.99)c 2.2 (1.4-3.1) 2.57 (1.75-3.77) 2.77 (1.85-4.16)c 6.0 (4.7-10.8) 0.92 (0.63-1.35) 0.91 (0.59-1.40)c
Sex:FEMALE
School
  1 Jinotega 25 161.2 (103.1-22.2) Ref Ref 26.1 (17.3-47.0) Ref Ref 1.2 (0.5-2.0) Ref Ref 8.6 (5.4-26.1) Ref Ref
  2 Masaya 25 118.6 (47.7-237.2) 0.68 (0.43-1.05) 0.67 (0.41-1.10)a 18.0 (11.7-27.5) 0.67 (0.43-1.04) 0.76 (0.46-1,26)a 1.4 (0.9-1.7) 1.34 (0.87-2.05) 1.25 (0.84-1.86)a 7.2 (5.0-9.0) 0.63 (0.40-1.01) 0.67 (0.40-1.12)a
  3 Chinandega 25 112.6 (57.9-142.5) 0.63 (0.40-0.98) 0.64 (0.39-1.04)a 37.6 (18.7-67.0) 1.27 (0.81-1.98) 1.28 (0.78-2.12)a 1.8 (1.4-2.5) 2.04 (1.33-3.12) 2.01 (1.36-2.96)a 7.2 (5.6-11.1) 0.68 (0.43-1.08) 0.73 (0.44-1.21)a
  4 Chinandega 25 93.4 (52.2-147.3) 0.61 (0.39-0.95) 0.48 (0.29-0.80)a 26.1 (16.3-77.3) 1.24 (0.79-1.93) 1.42 (0.84-2.41)a 2.2 (1.7-3.9) 2.75 (1.79-4.21) 2.52 (1.67-3.79)a 7.4 (5.5-10.9) 0.74 (0.47-1.17) 0.87 (0.51-1.47)a
Sex: MALE
School
  1 Jinotega 25 36.3 (24.3-42.8) Ref Ref 6.9 (5.0-9.7) Ref Ref 1.5 (0.4-2.7) Ref Ref 4.7 (3.5-5.3) Ref Ref
  2 Masaya 25 22.2 (9.1-38.24) 0.60 (0.38-0.93) 0.60 (0.36-1.00)a 7.4 (3.7-13.9) 1.15 (0.77-1.72) 1.35 (0.86-2.11)a 1.2 (0.7-1.5) 1.07 (0.56-2.05) 1.44 (0.71-2.94)a 7.1 (5.3-8.9) 1.43 (0.79-2.62) 1.49 (0.74-3.01)a
  3 Chinandega 25 25.5 (21.6-42.2) 0.93 (0.59-1.45) 0.87 (0.55-1.37)a 5.5 (2.9-6.8) 0.75 (0.50-1.12) 0.77 (0.52-1.15)a 1.5 (1.2-1.9) 1.98 (1.04-3.77) 2.17 (1.15-4.09)a 4.9 (4.1-7.5) 1.16 (0.64-2.11) 1.08 (0.58-2.02)a
  4 Chinandega 25 68.2 (27.4-97.3) 1.69 (1.08-2.65) 1.52 (0.93-2.50)a 8.3 (6.4-13.1) 1.23 (0.82-1.83) 1.56 (1.01-2.40)a 1.9 (1.3-2.9) 2.40 (1.26-4.58) 3.17 (1.59-6.33)a 5.5 (3.9-9.7) 1.15 (0.63-2.10) 1.10 (0.55-2.17)a
IL-18 NGAL NAG ACR
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6.4 Discussion 
This study is the first, to our knowledge, to focus on adolescents in the context of the CKD 
epidemic of unknown causes in the Central American region.  
In epidemiological studies, CKD is usually measured by use of the estimated glomerular 
filtration rate (eGFR), which is primarily determined by the concentration of serum creatinine. 
However, creatinine is not sufficiently sensitive to detect early kidney damage, and a new 
series of biomarkers have arisen in the last years to measure AKI, and predict progression to 
adverse clinical outcomes (Devajaran, 2011), and even a long term kidney function decline 
(Shilipak et al, 2013), We used some of these novel urine biomarkers of kidney damage, which 
had been employed in a previous study of the kidney function of sugar cane workers through a 
harvest season in Nicaragua. In that study, those workers engaged in tasks with the most 
exposure to heat and strenuous work showed a more pronounced decreased in their kidney 
function, associated with an elevation of some of these urine biomarkers (McClean et al, 
2012).  
For this study, we recruited adolescents in schools from three different regions of Nicaragua. 
Children from Schools 3 and 4 (in school 4 a child’s inclusion was restricted to parents with 
experience working on the sugar cane industry) resided in an area of high mortality and 
prevalence of CKDu. Results confirmed this fact; a third of fathers at school 4 self-reported 
CKD, and 13% had died. Our main a priori hypothesis was that students who attended school 
in areas of higher adult CKDu mortality would have higher levels of biomarkers than students 
in areas of lower mortality.    
Results from the study were generally in accordance with our a priori hypotheses, with result 
to risk of kidney injury by school. The results for NAG were most consistent in this regard, with 
the relative concentrations rank ordered by school according to risk profile in both boys and 
girls. Boys at the school 4, which we had hypothesized would have the highest prevalence of 
kidney damage, had elevated levels of NGAL, NAG, and IL-18 compared to boys at the school 1. 
Both boys and girls at both of the two schools in the Chinandega region (schools 3 and 4) had 
elevated levels of NAG compared to children at school 1. Thus, both schools in Chinandega 
demonstrated some evidence of kidney damage among both boys and girls, but only boys at 
school 4 exhibited the most consistent evidence across all three tubular biomarkers. It is 
notable that the biomarker ACR, which is primarily associated with glomerular damage, did not 
demonstrate these patterns, and macroalbuminuria measured with dipstick, was only present 
in one of the students.  
However, contrary to our expectations (since adult males generally have a higher prevalence 
of CKDu in Nicaragua), girls had higher mean levels than boys for all biomarkers, with 
particularly large differences for ACR and IL-18. These findings remained whether or not we 
adjusted the biomarkers concentrations for urine creatinine. Girls had higher urine creatinine 
concentrations and urine specific gravity than boys. If urine volumes were similar in boys and 
girls, we would expect urine creatinine concentration to be higher in boys, since boys usually 
excrete significantly more creatinine compared with girls before and during puberty (reflecting 
greater muscle mass) (Skinner et al., 1996; Trachtenberg et al, 2007). We hypothesize that girls 
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may suffer from a relative dehydration compared to boys, which may simply be from fluid 
restriction due to the greater propensity for girls (for hygiene or cultural reasons) to avoid 
using the toilet in a public setting. This phenomenon has been reported anecdotally in 
Nicaragua and other countries (e.g. cartoon vignettes). NGAL, for example, has been proposed 
in preliminary research as a very sensitive biomarker even in minimal and silent prerenal 
kidney dysfunction due to dehydration (Damman et al, 2011; Antonopoulos et al, 2011). In our 
study, girls had a median (IQR) of 26.1 ng/mg Creatinine (17.3-47), compared to 6.9 ng/mg 
Creatinine (5-9.7) in males. If adolescent girls turn out to be, in fact, at a greater risk of early 
kidney damage, this would imply that there is a later exposure to a progression factor for CKD 
that disproportionately affects males. Although adult women in the most affected 
communities have a higher prevalence of CKD compared to women in communities not 
affected (i.e., the same pattern as for males), the prevalence is still significantly lower than for 
males in the same communities (Torres et al, 2010; O’Donnell, 2010; Peraza et al, 2012). While 
it is perhaps likely that males have greater exposure than females to many of the hypothesized 
risk factors for CKDu (e.g., heat with accompanying volume depletion, leptospirosis, arsenic, 
agrichemicals) during adulthood as a result of gender differences in types of occupational, we 
have no evidence that exposure to such factors would be greater among girls than among boys 
among adolescents who have not yet entered the workforce (we excluded adolescents who 
had ever worked manually, whether paid or unpaid). The possible causes of the higher 
biomarkers among girls remain unknown and need to be taken into consideration in future 
studies. 
NSAIDs and antibiotics are widely used in the region to relieve a common dysuria-like 
syndrome in the community, and particularly among workers, locally called “chistata”, which is 
probably associated with dehydration and exposure to high temperatures (Ramirez-Rubio et 
al, 2013b). Although there were not significant differences by school, remarkably, a high 
percentage of children reported pain while urinating (46%), and “kidney” problems (13%), 
which included several symptoms and diseases, sometimes equating the terms urinary tract 
infections and kidney “insufficiency”. Dipstick results, though, did not show evidence of lower 
tract infections, since leukocyte esterase positivity appeared in around 10% of the population 
(mostly girls, with no differences between schools), and nitrites were mostly absent.  
One of the main limitations of this study is the absence of well-validated normal values for 
these biomarkers (except for albumin). In order for these biomarkers to serve as a screening 
tool of kidney damage, data available for comparison from a healthy reference population is 
needed. In this case, there are few studies in healthy schoolchildren or adolescents (Waring et 
al, 2011; Mazaheri, 2011; Misurac et al, 2013). Furthermore, lack of standardized laboratory 
methods, non-Gaussian distribution, and the absence of consensus reporting guidelines (e.g. 
units, excretion vs. concentration, adjusted or not for urine creatinine, etc) make comparisons 
with the published literature difficult (Jung, 1992; Csathy, 1995). The lack of well-defined 
standard values of these biomarkers in a comparable population, drove us, like it has been 
done in other settings (Kaneko et al, 2003; Stefanovic et al, 2009), to design the study such as 
the selected schools would represent different a priori CKD risks, with the one hypothesized 
with lowest risk as the reference school. Our sample size has enabled us to observe differences 
among schools, but may not be enough to explain the risk factors involved. 
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Also, another limitation of our study is that we were not able to access overnight or first 
morning urine samples, those are the preferred samples as exercise or changes in posture may 
affect urine biomarkers concentration outputs. Instead, we asked for early morning samples at 
the school, prior to any strenuous physical activity. We were also concern that some children 
may have walked long distances from home, but it turned out that only 21 (10%) walked for 
more than 30 minutes, and certainly, School 4 (the one with most a priori risk for kidney 
damage) presented the least percentage (5%) of children walking longer time.  
Overall, our results suggest some evidence of early-stage kidney damage in adolescents in 
Nicaragua with higher frequency in those schools and regions within Nicaragua that were 
defined with a priori more CKD risk. This finding is preliminary and needs confirmation with 
further investigation, but, if corroborated, it will be an important piece of information, not 
only for the children’s health, but also to investigate the susceptibility factors and causes of 
the CKD epidemic in Nicaragua and throughout Central America in the general population. 
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CONCLUSIONS/CONCLUSIONES 
“It is more than 10 years now that someone dies of CKD every week around me and no one 
does anything”. 
“Hace 10 años que cada semana alguien muere de IRC a mi alrededor y nadie hace nada”. 
-Donald Cortez  
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This thesis report have yielded the following conclusions: 
Regarding Objective 1: 
1.1-There is an epidemic of CKD of unknown causes, recently named Mesoamerican 
Nephropathy (MeN), which probably extends from South Mexico to Panama. Mortality rates 
and prevalence studies have confirmed that communities where agriculture, mining and port-
related occupations are prevalent, and particularly those in lowlands of the Pacific coast are 
the ones most affected.  Also, contrary to the typical distribution of a chronic [renal] disease, it 
affects primarily men in their 20-40s (relatively young). Women, although less affected, follow 
also the same distribution as men (e.g. higher prevalence’s in low altitude). 
1.2-Risk factors (susceptibility, initiation and/or progression) associated with CKDu in the 
different prevalence and case control studies to date have brought researchers to think that 
etiology is presumably multifactorial.  The variety of hypothesized causes include: heat and 
heavy physical work load (chronic volume depletion), exposure to heavy metals such as arsenic 
or cadmium, agrichemicals, systemic infectious diseases such as leptospirosis, and chronic 
intake of potential nephrotoxic medications such as non-steroidal anti-inflammatory drugs 
(NSAIDs), analgesics or aminoglycoside antibiotics.  
1.3-The epidemiological information on MeN/CKDu is still very limited, but has helped to 
describe the distribution of the disease and propose some risks factors. Main limitation of the 
mortality data is the variation in the extent of ascertainment of mortality data in the different 
countries and even within country regions, with plausible under-estimation in those areas 
where no active screening programs are taking place. Community- prevalence studies also 
present a number of limitations including its cross-sectional design (which generally does not 
allow any causal inference, and estimates prevalence with only one point in time measure), 
and the strong questionnaire-based assessments of risk factors with potential for exposure 
misclassification, such as recall bias).  
1.4-Further public health and research priorities to address gaps in knowledge include: 1) 
incident cases based on surveillance systems and a CKDu case definition, 2) basic information 
on the natural history and the clinical progression of the disease, 3) prevalence studies in 
additional areas selected on a systematic basis, 4) longitudinal studies capable of assessing 
incidence, progression, 5) burden of disease studies, quality of life, and social determinants of 
the disease. 
Regarding Objective 2: 
2.1-Semi-estructured interviews with Nicaraguan physicians and pharmacists working in the 
front line of the epidemic in Western Nicaragua were consistent with the existence of an 
epidemic of CKD, describing characteristics similar to those noted in the prevalence studies 
conducted in the region, including CKD being more frequent among men, starting in young 
adulthood, and associated with mainly agricultural work but also occurring in other manual 
occupations, and usually not with diabetes and hypertension. 
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2.2-Our analysis articulated perceptions of physicians and pharmacists in a causal framework 
where heat stress and subsequent volume depletion experienced by manual laborers plays a 
role in the frequent occurrence of dysuria-like symptoms (locally called “chistata”), which are 
often treated with non-steroidal anti-inflammatory drugs, diuretics and antibiotics that may be 
further nephrotoxic. 
Regarding Objective 3: 
3.1- Adolescents recruited at four schools from different regions of Nicaragua, showed 
biomarkers of kidney tubulo-interstitial damage in accordance with our a priori hypothesis 
(ranked by mortality rates in the general population).  For example, the results for NAG were 
most consistent in this regard, with the relative concentrations rank ordered by school 
according to risk profile in both boys and girls. 
3.2-Albumin-Creatinine Ratio, which is primarily associated with glomerular damage, did not 
demonstrate these patterns, and macroalbuminuria measured with dipstick, was virtually 
absent. 
3.3-An unusual finding is that girls had higher levels than boys for all biomarkers, with 
particularly large differences for ACR and IL-18.  We hypothesize that girls may suffer from a 
relative dehydration compared to boys, which may simply be from fluid restriction due to the 
greater propensity for girls (for hygiene or cultural reasons) to avoid using the toilet in a public 
setting, but this fact may need further confirmation.  
3.4-Results from this pilot study are preliminary and need to be the focus of further 
investigation, but if confirmed, it may indicate that early risk factors for CKD in the region may 
be present during teenage, prior to other additionally exposures.  
  
 88 
 
Las conclusiones que derivan de la investigación presentada en esta tesis son las siguientes:  
Respecto al Objetivo 1: 
1.1 La información basada en las tasas de mortalidad y en estudios de prevalencias confirman 
que ciertas comunidades dedicadas a la agricultura, minería, y trabajadores portuarios 
presentan prevalencias de ERC elevadas, particularmente aquellas comunidades localizadas a 
nivel del mar en la Costa del Pacífico. Al contrario de la típica distribución de enfermedad renal 
crónica, NeM afecta principalmente a hombres jóvenes de 20-40 años (relativamente jóvenes). 
Las mujeres, aunque se encuentran menos afectadas, también presentan una distribución 
similar a los hombres (Ej. mayor prevalencias en comunidades localizadas a menor altitud).   
1.2 Los factores de riesgo (susceptibilidad, iniciación y/o progresión) asociados a NeM en los 
diferentes estudios de prevalencia y de casos y controles hasta la fecha, así como aquellas 
causas ambientales conocidas de ERC que pudieran tener un papel en esta epidemia, han 
llevado a pensar que la etiología podría ser multifactorial. La variedad de las hipótesis causales 
incluye: exposición al calor y trabajo manual intenso (depleción de volumen crónica), 
exposición a metales pesados como cadmio, o a arsénico, agroquímicos, enfermedades 
infecciones sistémicas como la leptospirosis, el uso crónico de medicamentos potencialmente 
nefrotóxicas, tales como antiinflamatorias no esteroideas (AINEs), analgésicos o antibióticos 
aminoglucósidos.  
1.3 La información sobre la epidemiología de NeM es aún escasa y presenta múltiples 
limitaciones, pero ha sido esencial para describir la distribución de la enfermedad y proponer 
algunos factores de riesgo. La limitación principal que presentan los datos de mortalidad es la 
variabilidad existente entre los diferentes países o incluso entre regiones dentro de cada país 
en cuanto a la vigilancia y registro de muertes, con probables subestimaciones en las zonas 
donde no hay programas de detección de casos activos.  Los estudios comunitarios de 
prevalencia también presentan una serie de limitaciones, tales como su diseño transversal 
(que, por lo general, no permite ninguna inferencia causal, y cuyas estimaciones de 
prevalencia se basan en una única medida), y las evaluaciones de factores de riesgo basadas en 
cuestionarios con potencial para la clasificación errónea de exposición como, por ejemplo, el 
sesgo de memoria). 
1.4-Algunas de las prioridades de salud pública e investigación para hacer frente a las lagunas 
de conocimiento incluirían: 1) definición de caso de NeM y registro de casos incidentes por 
sistemas de vigilancia, 2) información básica sobre la historia natural y progresión clínica de la 
enfermedad, 3) estudios de prevalencia en otras regiones seleccionadas de forma sistemática, 
4) estudios longitudinales que permitan evaluar la incidencia y progresión de la enfermedad, 5) 
estudios de carga de enfermedad, calidad de vida, y determinantes sociales de la enfermedad.  
Respecto al Objetivo 2:  
-Los médicos y farmacéuticos entrevistados que trabajan en la primera línea de la epidemia 
describen la epidemia de manera consistente con los resultados llevados a cabo en la región.  
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-Nuestro análisis articuló las percepciones de médicos y farmacéuticos en un esquema de red 
causal donde el estrés por calor y la depleción de volumen subsecuente que experimentan los 
trabajadores manuales podrían jugar un papel en la aparición frecuente de síntomas similares 
a la disuria (llamados localmente “chistata”), que son normalmente tratados con 
antiinflamatorios no esteroideos, diuréticos y antibióticos que pueden ser también 
nefrotóxicas.    
Respecto al Objetivo 3: 
3.1- Los adolescentes de cuatro colegios en tres regiones diferentes de Nicaragua mostraron 
biomarcadores de daño renal túbulo-intersticial en un orden creciente igual a aquel que 
muestran las tasas de mortalidad por ERC en la población general de las regiones 
mencionadas.  Por ejemplo, los resultados para NAG fueron las más consistentes en este 
sentido, con concentraciones medias relativas por colegio ordenadas según el perfil de riesgo 
basado en las tasas de mortalidad por ERC en su región, tanto para chicos como para chicas.  
3.2- La razón albúmina-creatinina urinaria (RAC), asociada principalmente con daño 
glomerular, no demostró estos patrones, y no hubo evidencia de macroalbuminuria medida 
con tira reactiva de orina. 
3.3- Un hallazgo inusual fue que las chicas presentaron niveles superiores respecto a los chicos 
para todos los marcadores, con diferencias particularmente notorias para IL-18 y RAC. Nuestra 
hipótesis es que las chicas podrían sufrir de una deshidratación relativa comparada con los 
chicos, debido quizás a una restricción de fluidos debido a la mayor propensión de las chicas 
(por razones de higiene y culturales) para evitar usar el baño en lugares públicos, pero este 
hecho debe ser confirmado en el futuro.  
3.4- Los resultados de este estudio piloto son preliminares y requieren ser el foco de 
investigación en el futuro, pero si se confirman, podrían indicar que algunos factores de riesgo 
temprano para NeM podrían estar presentes durante la adolescencia, previamente a otras 
exposiciones adicionales.  
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RECOMMENDATIONS: OUTLINING 
PUBLIC HEALTH INTERVENTIONS 
FOR MeN/CKDu 
“Knowing is not enough; we must apply. Willing is not enough; we must do.” 
—Goethe (1749-1832)  
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Public health responses to the epidemic cannot wait until efforts to identify the causes are 
completed, especially because treatment is not widely available, and poverty, stigma, and 
premature death are key elements that have turned this disease into a real public health crisis 
of regional dimensions. 
Responses should address the various levels of actions proposed in the eco-health theoretical 
model (See Chapter II). The following recommendations are based on the general knowledge 
of the situation in Central America (including discussion with other researchers and public 
health officers) that I have acquired during the last five years, and the evidence presented in 
this document. These recommendations are also compiled in the annexed document “Brief 
Policy Paper: Epidemic of Chronic Renal Disease in Central America”, that was commissioned in 
May 2012 by Instituto de Salud Carlos III, as a request by the Ministry of Health of Costa Rica in 
the context of bilateral cooperation projects that both institutions share (see annexes). 
 
Multisectoral and multilevel public policies in Central America: CKD as 
a regional public health alert 
 From a macro perspective, mainstreaming health and environmental issues should be 
included and prioritize into development policies, with the aim to promote sustainable 
and equitable patterns of production (including working conditions) and consumption. 
 In particular, there is a need to build capacity to monitor and manage ecosystems and 
contaminants or hazardous exposures to human health (such as agrichemicals, heavy 
metals or extreme temperatures).  
 Institutions involved in these tasks should include an ecosystem perspective instead of 
operate just in human constructs and boundaries such as municipalities, and provinces 
or departments. 
 Strengthening field disease surveillance, joint animal-human epidemiological studies 
(essential to study, for example, leptospirosis) and health services development, 
seems essential to monitoring CKD incidence and its determinants at the population 
level. Ad-hoc surveillance of workers’ symptoms of heat exposure and workload, 
together with hydration practices, could be consolidated by governmental agencies 
and main employers. 
 
Health promotion and primary prevention linked with applied 
research 
 Target of community preventive health programs (including in settings such as the 
workplace or health centers) should be the possible association between the 
occupational exposure to heat and the use of potentially nephrotoxic medications.  
 Research into current hydration practices and promoters, and obstacles to greater 
hydration, could help shape public health recommendations.  
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 Common self-medication of widespread (across the community and particularly 
workers) dysuria related symptoms with diuretics, NSAIDs and antibiotics should be 
the target of greater oversight and health protection measures from government 
agencies.  
 Particularly important is the training of health workers and pharmacists, and the 
development of context-specific guidelines and protocols addressing a correct 
differential diagnosis and treatment of heat exposure symptoms, UTIs and CKD, and 
structured around patient safety and rational use of medicaments issues.  
 
Health Care Services: early detection and comprehensive treatment  
 Strengthen health care systems to provide both primary health care and renal 
replacement therapies (dialysis and/or transplantation), which constitute a huge 
burden in these Central American countries.  
 Develop evidence-based and context-oriented CKD clinical practice guidelines, and 
education of health professionals on their implementation.   
 Clinical practice should focus on early detection, regular monitoring and control of 
progression factors, nutritional aspects, social protection, and counseling for patients 
and families.  
 Working with communities on CKD related education and dissemination, improving 
understanding of the disease and existing treatments, and thus, tackling stigma.  
 
Regional Action Plan 
 CKDu/MeN has a wingspan of a regional public health problem, thus actions should 
have the same scope.  
 Fortunately, there have been very recently initiatives with this spirit: 
o Workshop on MeN nephropathy 2012, followed by a “declaration statement” 
and the creation of a “Research Consortium” with a Board of Directors, 
November 2012. 
o “High-level meeting on Chronic Kidney Disease of non-traditional causes in 
Central America”, and its “San Salvador Declaration”, organized by El Salvador 
Ministry of Health, and the participation of the Central American Ministries of 
Health (COMISCA), April 2013. 
o PAHO 152nd Executive Committee Meeting (June, 2013) discussed “chronic 
kidney disease in agriculture communities in Central America” and set up the 
conditions for a Regional Cooperation Program on this topic.  
 Actions should involve at different levels important organizations and stakeholders: 
government bodies, universities and researchers, health workers and patients, NGOs, 
employers and worker unions and associations, etc.). 
 
Taken together, the research and public health agendas described here constitute a significant 
task, but one that is achievable if these epidemics receive sufficient attention from scientific, 
public health, and development agencies. As expressed by one of the CKD patients in 
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Nicaragua: “We are a poor country, but it is very amazing to see how they mobilize money and 
human resources when it comes to malaria, which barely exists in my community, or influenza. 
But it is more than 10 years now that someone dies of CKD every week around me and no one 
does anything”. Simple words that describe a complex problem. The interrelated need for 
science and public health action are hardly unique to this epidemic, and the global health 
community has repeatedly demonstrated its capability to tackle this type of problem. It is our 
hope that the community will bring its considerable intellectual resources to identify the 
causes of this puzzling epidemic (paragraph taken from Ramirez-Rubio, 2013a). 
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ACR-Albumin Creatinine Ratio 
AKI- Acute kidney injury 
ASOCHIVIDA- Asociación Chichigalpa por la vida 
BEN- Balkan endemic nephropathy 
BQSC- Brookline-Quezalguaque sister city 
BUSPH- Boston University School of Public Health 
CAO- Compliance, advisory, ombudsmen 
CKD- Chronic Kidney Disease 
CKDu- Chronic Kidney Disease of unknown causes 
CISTA- Centro de Investigación en Salud, Trabajo y Ambiente (UNAN-Leon) 
COMISCA- Consejo de Ministros de Salud de Centroamérica 
CVD- Cardiovascular Disease 
DALY- Disability Adjusted Life Years 
GFR/eGFR- Glomerular filtration rate/ estimated glomerular filtration rate 
IL-18- Interleukin 18 
IRB- Institutional Review Board 
ISA- Ingenio San Antonio 
KDIGO- Kidney Disease: improving global outcomes 
K/DOQI- Kidney Disease outcome quality initiative 
MOE- Ministry of Education 
MoH- Ministry of Health 
MDRD- Modification of diet in renal disease study equation 
MeN- Mesoamerican Nephropathy 
NAG- N-acetyl-D-glucosaminidase 
NGAL- Neutrophil gelatinase-associated lipocain 
NHANES- National health and nutrition examination survey (USA) 
NKF- National Kidney Foundation 
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NSAIDs- Non-steroidal anti-inflammatory drugs 
NSEL- Nicaragua Sugar States Limited 
OR- Odds Ratio 
PAHO- Pan American Health Organization 
RRT- Renal replacement therapy 
SALTRA- Programa de Salud Trabajo y Ambiente en Centroamérica 
SCr- Serum Creatinine 
UNAN-Leon- Universidad Nacional de León (Nicaragua) 
UTI- Urinary tract infection 
WHO- World Health Organization 
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